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Abstract
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition
and Allergies (NDA) derived dietary reference values (DRVs) for thiamin (vitamin B1). The
Panel considers that data from depletion–repletion studies in adults on the amount of dietary thiamin
intake associated with the erythrocyte transketolase activity coefficient (aETK) < 1.15, generally
considered to reflect an adequate thiamin status, or with the restoration of normal (baseline)
erythrocyte transketolase activity, without a sharp increase in urinary thiamin excretion, can be used to
estimate thiamin requirement. In the absence of new scientific evidence, the Panel endorses the
average requirement (AR) of 0.072 mg/MJ (0.3 mg/1,000 kcal) for all adults proposed by the Scientific
Committee for Food (SCF) in 1993 on the basis of one depletion–repletion study, in which both aETK
and urinary thiamin excretion were measured. Results from other depletion–repletion studies are in
agreement with this value. The Panel agrees on the coefficient of variation of 20% used by the SCF to
cover uncertainties related to distribution of thiamin requirements in the general population, and
endorses the population reference intake (PRI) of 0.1 mg/MJ (0.4 mg/1,000 kcal) set by the SCF for
all adults. The same AR and PRI as for adults, expressed in mg/MJ, are proposed for infants aged
7–11 months, children aged 1 to < 18 years, and during pregnancy and lactation, under the
assumption that the relationship between thiamin requirement and energy requirement is the same in
all population groups.
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Summary
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and
Allergies (NDA) was asked to deliver a Scientific Opinion on Dietary Reference Values for the European
population, including thiamin (vitamin B1).
Thiamin is a water-soluble vitamin composed of a thiazole and a pyrimidine ring linked by a
methylene group. In human tissues, thiamin occurs mostly in phosphorylated forms as thiamin
monophosphate (TMP), thiamin diphosphate (TDP, called also thiamin pyrophosphate), thiamin
triphosphate (TTP), as well as its non-phosphorylated form (‘free thiamin’). Free thiamin functions as
the precursor for TDP, which acts as a coenzyme for enzymes involved in carbohydrate and branched-
chain amino acid metabolism, and in energy-yielding reactions. Thiamin deficiency leads to disorders
that include several forms of beriberi, with mostly neurological and cardiovascular manifestations.
Thiamin in food exists mainly in phosphorylated forms in animal products, and in free form in foods
of plant origin. Upon ingestion, thiamin phosphate esters are hydrolysed in the intestinal lumen by
phosphatases. Free thiamin is taken up through the mucosal membrane by a specific saturable
transport system. In healthy subjects, thiamin absorption is above 95% at usual intakes. Alcohol and
anti-thiamin factors (such as some phenolic compounds, sulfites and thiaminases) can reduce thiamin
bioavailability. Thiamin in blood is mainly found in erythrocytes (> 80% of total thiamin in the blood) in
the form of TDP and TTP, while low amounts of the vitamin are present in plasma, as free thiamin,
TMP and protein-bound TDP. Thiamin in the body is mostly located in the skeletal muscles, heart,
brain, liver and kidneys.
Urine is the main route of thiamin excretion, mainly in the form of free thiamin and thiamin
metabolites. The Panel notes that 24-h urinary thiamin excretion is related to thiamin intake,
particularly to short-term intakes, in thiamin-replete individuals. However, the thiamin intake cannot
reliably be estimated from the urinary excretion of the vitamin. The determination of 24-h urinary
thiamin excretion is not a reliable marker of thiamin body stores and cannot, on its own, be used as a
biomarker of the thiamin status of individuals. Still, in experimental studies where 24-h urinary thiamin
excretion is assessed in response to various intakes of the vitamin, a sharp increase in thiamin
excretion is considered to be indicative of the saturation of the thiamin body stores.
Measurement of the erythrocyte transketolase activity (ETKA), a TDP-requiring enzyme, is a
functional test of thiamin status. The erythrocyte transketolase activity coefficient (aETK, also called
‘TDP effect’) represents the degree to which ETKA rises in response to addition of TDP. This test can
discriminate low ETKA due to thiamin deficiency from a lack of the apoenzyme. A value of aETK < 1.15
is generally considered to reflect an adequate thiamin status. The concentrations of total thiamin (free
thiamin and its phosphate esters) in whole blood, serum and erythrocytes have also been investigated
as biomarkers of thiamin status. Erythrocyte TDP concentration was found to have similar performance
as the erythrocyte transketolase activation assay for assessment of thiamin status. The Panel notes,
however, the lack of established cut-offs for these biomarkers.
The Panel considers that data from depletion–repletion studies in adults on the amount of dietary
thiamin intake associated with aETK < 1.15 or with the restoration of normal (baseline) ETKA, without
a sharp increase in urinary thiamin excretion, can be used to estimate thiamin requirement. In the
absence of new scientific evidence, the Panel endorses the average requirement (AR) of 0.072 mg/MJ
(0.3 mg/1,000 kcal) for all adults set by the Scientific Committee for Food (SCF) in 1993 on the basis
of one depletion–repletion study in seven healthy males, in which both aETK and urinary excretion of
thiamin were measured. Results from other depletion–repletion studies are in agreement with this
value. The Panel notes that the AR was based on data on a small number of men, and agrees on the
coefficient of variation of 20% used by the SCF to cover uncertainties related to distribution of thiamin
requirements in the general population. The Panel endorses the population reference intake (PRI) of
0.1 mg/MJ (0.4 mg/1,000 kcal) set by the SCF for all adults. No new evidence has become available
that the relationship between thiamin requirement and energy requirement differs between men and
women, or between younger and older adults.
The Panel proposes the same AR and PRI as for adults, expressed in mg/MJ, for infants aged 7–11
months, children aged 1 to < 18 years old, and during pregnancy and lactation, under the assumption
that the relationship between thiamin requirement and energy requirement is the same in all
population groups.
Based on data from 13 dietary surveys in nine countries of the European Union, average thiamin
intakes across countries ranged between 0.31 and 0.65 mg/day (0.11–0.21 mg/MJ) among infants
(< 1 year old), between 0.58 and 0.98 mg/day (0.12–0.21 mg/MJ) among children aged 1 to < 3 years
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old, between 0.68 and 1.29 mg/day (0.10–0.21 mg/MJ) among children aged 3 to < 10 years old,
between 0.93 and 1.92 mg/day (0.11–0.20 mg/MJ) among children aged 10 to < 18 years old and
between 0.88 and 1.99 mg/day (0.11–0.24 mg/MJ) among adults (≥ 18 years old).
Dietary reference values for thiamin
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Background as provided by the European Commission
The scientific advice on nutrient intakes is important as the basis of Community action in the field
of nutrition, for example, such advice has in the past been used as the basis of nutrition labelling. The
Scientific Committee for Food (SCF) report on nutrient and energy intakes for the European
Community dates from 1993. There is a need to review and if necessary to update these earlier
recommendations to ensure that the Community action in the area of nutrition is underpinned by the
latest scientific advice.
In 1993, the SCF adopted an opinion on the nutrient and energy intakes for the European
Community.1 The report provided reference intakes for energy, certain macronutrients and
micronutrients, but it did not include certain substances of physiological importance, for example,
dietary fibre.
Since then new scientific data have become available for some of the nutrients, and scientific
advisory bodies in many European Union (EU) Member States and in the United States have reported
on recommended dietary intakes. For a number of nutrients, these newly established (national)
recommendations differ from the reference intakes in the SCF (1993) report. Although there is
considerable consensus between these newly derived (national) recommendations, differing opinions
remain on some of the recommendations. Therefore, there is a need to review the existing EU
Reference Intakes in the light of new scientific evidence, and taking into account the more recently
reported national recommendations. There is also a need to include dietary components that were not
covered in the SCF opinion of 1993, such as dietary fibre, and to consider whether it might be
appropriate to establish reference intakes for other (essential) substances with a physiological effect.
In this context, the European Food Safety Authority (EFSA) is requested to consider the existing
population reference intakes (PRIs) for energy, micro- and macronutrients and certain other dietary
components, to review and complete the SCF recommendations, in the light of new evidence, and in
addition advise on a PRI for dietary fibre.
For communication of nutrition and healthy eating messages to the public, it is generally more
appropriate to express recommendations for the intake of individual nutrients or substances in food-
based terms. In this context, EFSA is asked to provide assistance on the translation of nutrient-based
recommendations for a healthy diet into food-based recommendations intended for the population as a
whole.
Terms of reference as provided by the European Commission
In accordance with Article 29(1)(a) and Article 31 of Regulation (EC) No 178/20022, the
Commission requests EFSA to review the existing advice of the SCF on PRIs for energy, nutrients and
other substances with a nutritional or physiological effect in the context of a balanced diet which,
when part of an overall healthy lifestyle, contribute to good health through optimal nutrition.
In the first instance, the EFSA is asked to provide advice on energy, macronutrients and dietary
fibre. Specifically, advice is requested on the following dietary components:
• carbohydrates, including sugars;
• fats, including saturated fatty acids, polyunsaturated fatty acids and monounsaturated fatty
acids, trans fatty acids;
• protein;
• dietary fibre.
Following on from the first part of the task, the EFSA is asked to advise on PRIs of micronutrients
in the diet and, if considered appropriate, other essential substances with a nutritional or physiological
effect in the context of a balanced diet which, when part of an overall healthy lifestyle, contribute to
good health through optimal nutrition.
Finally, the EFSA is asked to provide guidance on the translation of nutrient-based dietary advice
into guidance, intended for the European population as a whole, on the contribution of different foods
or categories of foods to an overall diet that would help to maintain good health through optimal
nutrition (food-based dietary guidelines).
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Assessment
1. Introduction
In 1993, the SCF adopted an opinion on the nutrient and energy intakes for the European
Community (SCF, 1993). The SCF set an average requirement (AR) and a PRI for thiamin, expressed in
lg/MJ, which applied to all age and sex groups. PRIs expressed in mg/day were also derived,
considering the average energy requirements of infants, children, adults, and pregnant and lactating
women. A lower threshold intake (LTI) expressed in lg/MJ was set for all age and sex groups, and
converted to mg/day for adults, again using the values for average daily energy requirements for men
and women.
2. Definition/category
2.1. Chemistry
Thiamin, also called vitamin B1 or aneurine, is a water-soluble vitamin. Thiamin is chemically
defined as 3-[(4-amino-2-methyl-5-pyrimidinyl) methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium,
with molecular formula C12H17N4OS and a molecular mass of 265.35 Da. Thiamin is composed of a
thiazole and a pyrimidine ring linked by a methylene group.
In human tissues, thiamin occurs mostly in phosphorylated forms as thiamin monophosphate
(TMP), thiamin diphosphate (TDP, called also thiamin pyrophosphate) (Figure 1), thiamin triphosphate
(TTP), as well as its non-phosphorylated form (‘free thiamin’). Adenosine thiamin triphosphate (ATTP)
is also found in some tissues (Gangolf et al., 2010) (Section 2.3.3).
There are different methods of measurement of thiamin content in foods and biological samples
(urine, blood and other tissues), such as high-performance liquid chromatography (HPLC) followed by
fluorescence or ultraviolet detection, fluorimetry and microbiological assay (Icke and Nicol, 1994; Lynch
and Young, 2000; Talwar et al., 2000; Mickelsen and Yamamoto, 2006). Techniques based on
fluorimetric detection involve the oxidation of thiamin into thiochrome (Fayol, 1997). These methods
showed comparable performance in foods (Hollman et al., 1993). The analytical procedure may
comprise a step of enzymatic hydrolysis of phosphorylated thiamin, allowing the quantification of total
thiamin content. The amounts of the respective forms of thiamin (i.e. free thiamin and its phosphate
esters) can be determined after separation by HPLC (Gangolf et al., 2010).
N N+
S
CH3
NH2
N
O P O
O
P OH
O
OHOH
CH3
N N+
S
CH3
NH2
N
OH
CH3
Thiamin
Thiamin diphosphate
Figure 1: The thiamin and thiamin diphosphate molecules
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2.2. Function of the nutrient
2.2.1. Biochemical functions
Free thiamin functions as the precursor for TDP, which acts as a coenzyme for enzymes involved in
carbohydrate and branched-chain amino acid metabolism, and in energy-yielding reactions. TDP is
needed for the activity of pyruvate dehydrogenase responsible for the conversion of pyruvate to
acetyl-coenzyme A, a-ketoglutarate dehydrogenase converting a-ketoglutarate to succinyl-coenzyme A
within the Krebs cycle, and branched-chain a-keto acid dehydrogenase involved in the oxidation of the
a-keto acids from branched-chain amino acids. These enzyme complexes play a key role in processes
related to mitochondrial energy metabolism. TDP is also the coenzyme for transketolase in the pentose
phosphate pathway, which is essential for the generation of pentoses and nicotinamide adenine
dinucleotide phosphate (NADPH) (Singleton and Martin, 2001; Combs, 2008; Lonsdale, 2012; Manzetti
et al., 2014). TDP is required for the function of the brain and nervous system as acetyl-coenzyme A
and a-ketoglutarate are involved in the production of the neurotransmitters acetylcholine and gamma-
aminobutyric acid.
TDP may be further phosphorylated to TTP. TTP is able to phosphorylate proteins and to activate
large conductance anion channels as, e.g. a chloride channel in nerves (Bettendorff et al., 1993;
Nghiem et al., 2000; Bettendorff and Wins, 2009). The precise physiological role of TTP has not yet
been elucidated (Bettendorff et al., 2014).
2.2.2. Health consequences of deficiency and excess
2.2.2.1. Deficiency
Thiamin deficiency usually presents with symptoms of peripheral neuritis, cardiac insufficiency and a
tendency for oedemas and may be accompanied by extreme fatigue, irritability, forgetfulness, poor
coordination, gastrointestinal disturbances, constipation, laboured breathing, loss of appetite and
weight loss (WHO, 1999).
Thiamin deficiency leads to disorders that include several forms of beriberi, with mostly neurological
and cardiovascular manifestations. Dry beriberi is predominately a neurological disorder with a sensory
and motor peripheral neuropathy. Wet beriberi is the term used for thiamin deficiency that, in addition
to the presence of peripheral neuropathy, involves cardiovascular manifestations that include
congestive heart failure, cardiomegaly and tachycardia. A rapidly developing form of wet beriberi refers
to the acute fulminant cardiovascular beriberi (Shoshin beriberi), or acute pernicious beriberi. Infantile
beriberi can occur in breastfed infants of thiamin-deficient mothers at the age of 2–6 months and may
be characterised by both neurologic and cardiac signs with lethal outcome due to heart failure
(Roman-Campos and Cruz, 2014; Abdou and Hazell, 2015). Infantile thiamin deficiency was described
in infants fed a soy-based thiamin-deficient infant formula (Fattal-Valevski et al., 2005). Lack of thiamin
impairs metabolic functions of the brain and can lead to Wernicke’s encephalopathy, which is clinically
characterised by ocular abnormalities, ataxia, and disturbances of consciousness, and to Korsakoff’s
syndrome (psychosis) resulting in amnesia, disorientation and often confabulation (Harper et al., 1986;
Gui et al., 2006; Sechi and Serra, 2007; Kopelman et al., 2009).
Thiamin deficiency occurs predominantly in populations whose diet consists mainly of poor sources
of thiamin (as milled white cereals, including polished rice and white wheat flour). It can also be
related to diets that are rich in thiaminase, a natural thiamin-degrading enzyme, which is abundantly
present in some raw or fermented fish, ferns and insects consumed primarily in Africa and Asia (WHO,
1999). In Western countries, thiamin deficiency is associated with alcoholism and drug abuse, and can
occur in other risk groups including subjects after bariatric surgery, gastrectomy, or with chronic
gastrointestinal and liver disorders (Lonsdale, 2012; Crook and Sriram, 2014).
2.2.2.2. Excess
Reviewing the evidence to set a tolerable upper intake level (UL) for thiamin, the SCF noted that
data on adverse effects of oral intake of thiamin in humans were limited and that dose–response
studies were lacking (SCF, 2001). The SCF also noted that thiamin absorption declines for an intake
higher than 5 mg/day and absorbed thiamin is actively excreted in the urine. No lowest-observed-
adverse-effect level (LOAEL) or no-observed-adverse-effect level (NOAEL), and therefore, no UL, could
be set for thiamin.
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2.3. Physiology and metabolism
2.3.1. Intestinal absorption and bioavailability
Thiamin in food exists mainly in phosphorylated forms in animal products, and in free form in foods
of plant origin. Thiamin phosphate esters are hydrolysed in the intestinal lumen by phosphatases,
mainly the alkaline phosphatase associated with brush-border membranes. Free thiamin is taken up
through the mucosal membrane by a specific saturable transport system (Laforenza et al., 1997;
Reidling et al., 2002). Two transporters, ThTR-1 and ThTR-2, encoded by SLC19A2 and SLC19A3
genes, are involved in intestinal thiamin uptake (Said et al., 2004). In case of low dietary thiamin
intake, an enhanced expression of ThTR-2 is induced, but not of ThTR-1 (Laforenza et al., 1997;
Reidling et al., 2002; Said et al., 2004).
When two healthy young men received an oral dose of 0.67 mg 2-14C-thiazole-labelled thiamin
(50 lCi) and a controlled diet providing a constant thiamin intake (range 1.35–2.10 mg/day, mean
1.75 mg/day), less than 1% of the radioactivity dose was found in the first and second day faecal
samples (Ariaey-Nejad et al., 1970). Overall, less than 5% of the labelled dose was found in the 5-day
faecal collection. In another study which involved 10 healthy individuals who received a dose of 1 mg
of 2-14C-thiazole-labelled thiamin (10 lCi), mean faecal excretion was 4  6.1% during the first 24 h
after administration (Tomasulo et al., 1968).
The efficiency of thiamin absorption is reduced upon consumption of thiamin above 5 mg/day,
(Friedemann et al., 1948; Davis et al., 1984). When thiamin was infused directly into the lumen of the
small intestine of humans and animals, it was absorbed by an active process at low concentrations
(0.2–2.0 lM (0.05–0.50 mg/L)) and by a passive process at higher concentrations (5.0–50.0 lM
(1.3–13 mg/L)) (Hoympa et al., 1975; Hoympa et al., 1982; Hoympa, 1982).
Chronic alcohol consumption impairs the intestinal absorption of thiamin, possibly through the
inhibition of thiamin transporters (Subramanya et al., 2010). In the above-mentioned study from
Tomasulo et al. (1968), significantly lower absorption of thiamin was found in 20 chronic alcoholic
individuals (mean faecal excretion of labelled thiamin 21  13.9%), compared to the 10 healthy
controls (4  6.1%).
Bioavailability of dietary thiamin can also be impaired by different types of anti-thiamin factors
present in some foods. These factors degrade or modify thiamin so that it cannot be absorbed or loses
its function. Sulfites, which are added to foods as a preservative, destroy thiamin at the methylene
bridge. Thiamin can also be degraded by thermolabile thiaminases present in some raw or fermented
fish, ferns and insects (Combs, 1992; WHO, 1999). Plants may contain heat-stable thiamin
antagonists, such as some aromatic acids (e.g. caffeic acid, chlorogenic acid, and tannic acid), which
can oxidise the thiazole ring, making thiamin absorption impossible. Flavonoids, quercetin and rutin,
have also been implicated as thiamin antagonists (Kositawattanakul et al., 1977; Hilker and Somogyi,
1982; Vimokesant et al., 1982). The bioavailability of thiamin was found to be reduced in controlled
studies comparing diet with and without tea (Wang and Kies, 1991; Saeed and Zaheer-ud-Din, 1996).
Microbiota of the large intestine can synthesise thiamin in the form of TDP. In vivo experiments
suggested that thiamin derived from bacterial synthesis is not used as a source of the vitamin
(Alexander and Landwehr, 1946; Denko et al., 1946). More recently, free thiamin was found to be
taken up by isolated human colonic epithelial cells via a process similar to the one occurring in the
small intestine. A specific regulated high-affinity carrier-mediated uptake system (encoded by SLC44A4
gene) for TDP was also identified (Nabokina et al., 2015). Further studies are needed to determine
whether TDP synthesised by microbiota may be used by colonocytes.
The Panel notes that data on the efficiency of thiamin absorption are limited. In healthy subjects,
thiamin absorption was found to be above 95% of daily thiamin intake lower than 2 mg, as determined
by the absorption of 14C-labelled thiamin. The Panel notes that alcohol and anti-thiamin factors (such
as some phenolic compounds, sulfites and thiaminases) can reduce thiamin bioavailability.
2.3.2. Transport in blood
Thiamin is transported by a high-affinity transporter into erythrocytes, where it is phosphorylated to
TDP, a fraction of which is further converted to TTP (Gangolf et al., 2010). As a result, thiamin in blood
is mainly found in erythrocytes (> 80% of total thiamin in the blood) in the form of TDP and TTP, while
low amounts of the vitamin are present in plasma, as free thiamin, TMP and protein-bound TDP
(Gangolf et al., 2010).
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2.3.3. Distribution to and content in tissues
Thiamin is taken up by cells of the blood, liver, heart and other tissues, including the placenta and
brain, by active transport, mostly through thiamin transporters ThTR-1 and ThTR-2. In addition, the
reduced folate carrier-1 (encoded by SLC19A1 gene) provides a minor access route for TMP, TDP and
TTP but not free thiamin. Members of the human extraneuronal monoamine transporter proteins,
including the organic cation transporter proteins, are active in the transport of amine forms of
nutrients and neurotransmitters, including thiamin, to the neurons (Zhao and Goldman, 2013; Manzetti
et al., 2014).
The total thiamin content of the adult body has been estimated to be about 25–30 mg, located
mostly in the skeletal muscles, heart, brain, liver and kidneys (Ariaey-Nejad et al., 1970; Manzetti
et al., 2014). Analysis of biopsies from various human tissues shows that TDP is the most abundant
thiamin compound, with the highest content in the heart and skin, followed by the kidney, lung, colon,
adipose tissue, skeletal muscle and vascular samples (content from 9  6 to 66  44 pmol/mg
protein). The content of other forms is low: TMP content ranged from 0.7  0.4 to 3.6  0.8 pmol/mg
protein in most tissues except the kidney with a content of 80 pmol/mg protein; TTP content ranged
from 0.3  0.2 to 3  4 pmol/mg protein; and free thiamin content ranged from 0.07 pmol/mg
protein in the colon to 3.5 pmol/mg protein in the kidney (Gangolf et al., 2010). In some tissues (lung,
thymus, skin, skeletal muscle, adipose tissue, arteries and veins), ATTP has also been found
(0.13  0.05 to 7  9 pmol/mg protein). Analysis of distribution between subcellular fractions has
shown that in most tissues, about 50% of the total thiamin occurs in the soluble fraction, 35% in
mitochondria, 10% in the nuclei and 5% in the microsomal fraction (Rucker et al., 2007). Free thiamin
or TMP cross the cell membranes and can be found in extracellular fluids including the cerebrospinal
fluid (Manzetti et al., 2014).
The biological half-life of the vitamin was found in the range of 9–18 days (Ariaey-Nejad et al.,
1970; Manzetti et al., 2014).
2.3.4. Metabolism
In cells, two enzymes phosphorylate thiamin: thiamin diphosphokinase, which catalyses the
formation of TDP from free thiamin using adenosine triphosphate (ATP), and TTP-ATP-
phosphoryltransferase, which catalyses the formation of TTP from TDP and ATP. TTP and TDP are
catabolised by thiamin pyrophosphatase yielding TMP. TMP can be recycled to free thiamin or is
excreted in the urine. Free thiamin as well as numerous thiamin metabolites formed in the liver are
also excreted via urine (Combs, 2008; Ross et al., 2014) (Section 2.3.5.1).
2.3.5. Elimination
2.3.5.1. Urine
Thiamin is excreted in urine as free thiamin, small amounts as TMP and TDP, the oxidation product
thiochrome, and more than 20 metabolites such as acid metabolites (2-methyl-4-amino-5-pyrimidine
carboxylic acid, 4-methylthiazole-5-acetic acid, and thiamin acetic acid) and a 25-kDa thiamin
containing peptide (Ariaey-Nejad et al., 1970; Combs, 2008; Ross et al., 2014). Thiamin that is not
bound to plasma proteins is rapidly filtered in the glomerulus and excreted (Bender, 2003).
Urinary excretion varies with the level of thiamin intake. Thiamin depletion is associated with a
marked decrease in thiamin excretion (Ziporin et al., 1965a,b; Kraut et al., 1966; Bamji, 1970;
Sauberlich et al., 1979), while the urinary excretion rate increases with increasing thiamin intakes
(Alexander et al., 1946; Mickelsen et al., 1947; Kraut et al., 1966; Davis et al., 1984; Shibata et al.,
2014) (Section 2.4.3). An enzyme which rapidly dephosphorylates unbound TDP was identified in
human plasma, and this may facilitate excretion of an excess of the vitamin (Thom et al., 1985).
The Panel notes that urine is the main route of thiamin excretion, mainly in the form of free thiamin
and thiamin metabolites.
2.3.5.2. Faeces
Significant amounts of thiamin are excreted in faeces (in the order of 0.10–0.40 mg/day)
(Alexander, 1943; Hathaway and Strom, 1946; Boyden and Erikson, 1966). At usual levels of intake,
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faecal excretion of thiamin is not related to thiamin intake (Hathaway and Strom, 1946; Boyden and
Erikson, 1966); an increase in thiamin excretion in the stool was observed with thiamin intakes above
5 mg/day (Schultz et al., 1938; Alexander, 1943). Thiamin in faeces arises mainly from its biosynthesis
by gut microorganisms, and is largely present within bacterial cells (Najjar and Holt, 1943; Alexander
and Landwehr, 1946). Upon parenteral administration of thiamin, no significant increase in faecal
thiamin was observed, which indicates that thiamin is not secreted into the gastrointestinal tract
(Alexander, 1943).
The Panel notes that faecal thiamin is not related to thiamin intake in the usual range of intake.
Significant amounts of thiamin are synthesised by gut microorganisms, which are not bioavailable and
are excreted in faeces.
2.3.5.3. Sweat
Sweat may contain up to 8–16 lg/L of thiamin (Bender, 2003).
The Panel notes that sweat does not represent a significant route of thiamin loss.
2.3.5.4. Breast milk
Thiamin is present in breast milk mostly as TMP (about 70%) and free thiamin (about 30%), while
a negligible amount of TDP has been reported (less than 1%) (Stuetz et al., 2012a,b). The
concentration of thiamin is lower in colostrum (1–5 days) and transitional milk (5–13 days) than in
mature milk, and the concentration remains constant during the rest of the lactation (Roderuck et al.,
1945; Ford et al., 1983; Dostalova et al., 1988). Maternal thiamin intake does not significantly affect
the thiamin concentration in breast milk, except in women deficient in the vitamin (Picciano, 1995;
Coats et al., 2013). Nail et al. (1980) and Thomas et al. (1980) found about 10% difference in thiamin
breast milk concentrations between supplemented (1.7 mg/day of thiamin as part of a multivitamin
supplement) and non-supplemented mothers.
Thiamin concentrations in breast milk from healthy mothers of term infants in Western countries
are shown in Appendix A. The mean thiamin concentrations in mature breast milk ranged from 0.14 to
0.22 mg/L (midpoint 0.18 mg/L) (Roderuck et al., 1945; Nail et al., 1980; Thomas et al., 1980; Ford
et al., 1983; Dostalova et al., 1988; Ortega et al., 2004).
Considering an average milk transfer of 0.8 L/day during the first 6 months of lactation in
exclusively breastfeeding women (Butte et al., 2002; FAO/WHO/UNU, 2004; EFSA NDA Panel, 2009),
and a concentration of thiamin in mature breast milk of 0.18 mg/L, the secretion of thiamin into milk
during lactation is estimated to be 0.15 mg/day.
2.3.6. Interaction with other nutrients
TDP is involved in many metabolic processes in which it serves as a coenzyme (Section 2.2.1). The
three dehydrogenases for which TDP acts as a cofactor require other cofactors derived from
pantothenic acid, riboflavin, and niacin (Frank, 2015). Transketolase activation depends on thiamin as
well as divalent cations, such as Ca2+ and Mg2+ (Kochetov, 1982; Ospanov et al., 2007). Magnesium
deficiency has been reported to aggravate thiamin deficiency in humans (Dyckner et al., 1985).
Thiamin is involved in carbohydrate metabolism (Section 2.2.1). In an intervention study, the
influence of a stepwise increase in carbohydrate contribution to energy intake on urinary and blood
thiamin concentration and the erythrocyte transketolase activity (ETKA) was studied in 12 healthy
volunteers (six men and six women, aged 25–30 years) consuming defined isocaloric diet
(9.1  3.0 MJ/day) and with a constant level of physical activity (Elmadfa et al., 2001). During a 4-day
adaptation phase (period I), the carbohydrate intake was 55% of total energy intake and the thiamin
intake was 0.13 mg/MJ. During the subsequent intervention periods, the carbohydrate intake was
increased to 65% of total energy for 4 days (period II) and to 75% for another 4 days (period III),
and the thiamin intake was 0.10 and 0.11 mg/MJ, respectively. No significant differences in
transketolase activity were found in periods II and III compared to that measured in period I, while
the mean blood thiamin concentration and urinary excretion of thiamin decreased significantly.
The Panel notes that there are limited data on the relationship between thiamin requirement and
carbohydrate intake in humans.
2.3.7. Energy intake and expenditure
In two studies, which compared thiamin status in physically active subjects and less active controls,
no difference between groups was found in erythrocyte transketolase activation coefficients (Fogelholm
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et al., 1992; Malara et al., 2013). In these studies, energy intakes were significantly higher in the
active groups than in the less active groups, while thiamin intakes, expressed in mg/MJ, were
comparable. The Panel notes that in these studies no alteration in erythrocyte transketolase activation
coefficient (aETK) was found when enhanced energy expenditure was accompanied by increased
thiamin intake. In a longitudinal study in swimmers, a significant decline in blood thiamin
concentrations (by 13% in men and 19% in women, respectively) after an intensive training associated
with enhanced energy expenditure, as compared to the control period, was observed (Sato et al.,
2011). There was no significant difference in mean dietary thiamin intakes between the study periods
(1.28 vs 1.54 mg/day, assessed by 3-day food records). When expressed in mg/MJ, women had a
lower thiamin intake during the training period than during the control period (control vs training:
0.131 vs 0.107 mg/MJ, p = 0.033), while intakes were similar in the two periods in men (control vs
training: 0.105 vs 0.109 mg/MJ). The Panel notes that no other marker than thiamin blood
concentration was measured in this study, which makes the study difficult to interpret.
The depletion–repletion study by Sauberlich et al. (1979) aimed at relating thiamin requirement to
energy utilisation (Section 5.1.1). Seven subjects were assigned to diets providing controlled intakes of
thiamin and either 2,800 or 3,600 kcal, and constant weights of the subjects were maintained by
adjusting daily activity and exercise schedules. Thiamin requirements were evaluated in terms of aETK
and urinary excretion of the vitamin (see Sections 2.4.2 and 2.4.3). A daily intake of 0.84 mg thiamin/
day failed to restore normal aETK in subjects with an energy intake of 3,600 kcal/day, while this
amount was associated with adequate aETK in subjects with 2,800 kcal/day. At this level of intake,
subjects with an energy intake of 3,600 kcal/day had lower urinary excretion of thiamin than subjects
with 2,800 kcal/day. When both groups received a similar amount of thiamin per energy unit
(0.072 mg/MJ, corresponding to 0.84 and 1.08 mg/day in the respective groups), no difference in
urinary thiamin excretion between groups was found and adequate aETK were achieved in both
groups. The Panel notes that this study indicates a positive relationship between thiamin requirement
and energy intake and expenditure.
The Panel notes that thiamin is involved in energy-yielding reactions (Section 2.2.1). The Panel also
notes that data on the relationship between thiamin requirement and energy requirement are limited;
however, available data indicate a positive relationship between thiamin requirement and energy
requirement.
2.4. Biomarkers of intake and status
2.4.1. Whole blood, serum and erythrocyte thiamin concentrations
The concentrations of total thiamin (free thiamin and its phosphate esters) in whole blood, serum
and erythrocytes have been investigated as biomarkers of thiamin status. In Western healthy
populations, concentrations of total thiamin in whole blood are typically in the range of 70–190 nmol/L
(Schrijver et al., 1982, 1985; Laschi-Loquerie et al., 1992; Lu and Frank, 2008). The major part of
thiamin is present in erythrocytes. Concentrations of total thiamin in the serum fraction are between
10 and 20 nmol/L. Whole blood TDP concentration in the range of 90–220 nmol/L, TMP 1–10 nmol/L,
TTP 1–13 nmol/L and free thiamin 2–15 nmol/L have been reported (Warnock et al., 1978; Lu and
Frank, 2008; Gangolf et al., 2010). Lower total thiamin concentrations have been reported in whole
blood of beriberi patients (Kawai et al., 1980; Kuriyama et al., 1980) and in erythrocytes of alcoholic
subjects (Mancinelli et al., 2003; Ceccanti et al., 2005), compared to healthy individuals. In a
longitudinal study in which four young adults were maintained on a constant diet for 60 days (1.55 mg
thiamin/day), within-subject variation in whole blood total thiamin concentration in the order of 8–10%
was reported (van Dokkum et al., 1990). In this study, mean ( standard deviation (SD)) total thiamin
concentrations varied between 130  11 and 166  19 nmol/L across subjects, indicating substantial
between-subjects variation with a similar level of thiamin intake.
Particular attention has been paid to the use of TDP concentrations in erythrocytes as a marker of
low thiamin status. In rats on a thiamin-deficient diet, erythrocyte and liver TDP concentration begun
to be depleted before any change in the erythrocyte transketolase activity was detected, suggesting
that erythrocyte TDP levels may be a more sensitive indicator of thiamin status (Warnock et al., 1978).
In humans, Talwar et al. (2000) found that measures of TDP concentrations in erythrocytes compared
well with the erythrocyte transketolase activity. The two methods were in agreement for 58 of 63
individuals. A total of 14 individuals were considered to be thiamin deficient by the transketolase
activation test (cut-off value: > 1.25), and 13 of them also had erythrocyte TDP concentrations lower
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than the reference range established in the study (95% reference interval: 280–590 ng/g Hb). Four
individuals with low TDP concentrations had the aETK ≤ 1.25, although they were close to the cut-off
(1.21–1.23). Measures of TDP in erythrocytes or whole blood have been used to assess thiamin status
in populations (Hanninen et al., 2006; Brough et al., 2007; Stuetz et al., 2012a; Whitfield et al., 2015),
with different cut-off values applied by the respective research groups. Wilkinson et al. (2000)
reported lower mean (95% CI) erythrocyte TDP concentrations in 221 older healthy subjects (149
(137–160) nmol/L) compared to 100 younger adults (224 (213–235) nmol/L) and erythrocyte TDP
concentrations were found to decrease as age progressed (20 (14.5–24.5)% over 3 years).
In the usual range, these biomarkers are not related to the observed habitual thiamin intake and
their response to thiamin supplementation is modest. In observational studies in populations with
mean thiamin intake between 0.9 and 1.2 mg/day, no significant correlations between thiamin intake
and total thiamin concentrations were found in whole blood, serum or erythrocytes (Bailey et al.,
1994; Hiraoka, 2001) and no or poor (r = 0.268; p < 0.05) correlations were found between thiamin
intake and TDP concentration in whole blood (Fidanza et al., 1989; Ihara et al., 2005). A study in
pregnant women who received thiamin supplementation (n = 41; 3 mg thiamin/day for around
20 weeks) or a placebo (n = 25) showed no significant difference in mean concentration of TDP in
whole blood (mean ( SD) 100.3  41.6 nmol/L vs 88.7  36.8 nmol/L) (Brough et al., 2007). In
healthy adults (aged 20–55 years), high intake of thiamin (5–15 mg/day) resulted in modest increases
in serum or whole blood concentrations of thiamin, while an active excretion of the vitamin in urine
was observed (Davis et al., 1984; Shibata et al., 2014), indicating that blood thiamin concentration is
regulated by the urinary excretion of the vitamin, besides reduced intestinal absorption.
The Panel notes that thiamin deficiency is generally associated with ‘low’ total thiamin or TDP
concentrations in whole blood and erythrocytes. The Panel also notes that the determination of TDP
concentration in erythrocytes had similar performance as the erythrocyte transketolase activation assay
to assess thiamin status. The Panel notes, however, the lack of established cut-offs for these
biomarkers. In the usual range of intake, total thiamin or TDP concentrations in whole blood and
erythrocytes are not valid markers of thiamin intake.
2.4.2. Erythrocyte transketolase activity (ETKA) and erythrocyte transketolase
activity coefficient (aETK)
Erythrocyte transketolase is a TDP-requiring enzyme. Measurement of its activity (ETKA) is a
functional test of thiamin status. Different methods of determination can be used (McCormick and
Greene, 1994), based on the rate of substrate utilised (e.g. ribose-5-phosphate) or product formed
(e.g. fructose-6-phosphate, sedoheptulose-7-phosphate) in the two reactions catalysed by the enzyme
(Section 2.2.1). ETKA can be measured without (basal) or with (stimulated) added TDP. aETK (also
called ‘TDP effect’) represents the degree to which ETKA rises in response to addition of TDP and
corresponds to the ratio of stimulated to basal enzyme activity, sometimes expressed as a percentage
(i.e. percentage of activation when TDP is added). This effect can discriminate low ETKA due to
thiamin deficiency from a lack of the apoenzyme (Sauberlich, 1999).
The erythrocyte transketolase activity coefficient may be regarded as a continuum with aETK value
increasing progressively from values close to 1, when the level of saturation of the enzyme with its
cofactor is high, to higher values as thiamin deficiency develops, until severe deficiency symptoms
occur (Lonsdale, 2012). Based on experimental thiamin deficiency studies in which aETK and urinary
excretion of thiamin were assessed in individuals maintained on controlled intakes of thiamin (Brin,
1962; Sauberlich, 1967; Wood et al., 1980), classifications have been proposed for the interpretation
of results of aETK in the assessment of thiamin status. In these studies, aETK in control subjects were
typically below 10%, while in individuals receiving a thiamin-depleted diet aETK was found to
progressively increase by up to more than 30% after several weeks of depletion. In general,
aETK ≤ 1.15 (≤ 15%) is considered as an indicative of an adequate thiamin status, aETK values 1.15–1.25
(15–25%) as a marker of insufficiency, while aETK > 1.25 (> 25%) is considered as an indicator of
thiamin deficiency (IOM, 1998; WHO, 1999). These cut-off values have been applied to assess thiamin
status of population groups (Duffy et al., 1981; Mataix et al., 2003; Wolters et al., 2003; Yang et al.,
2005; Shaw et al., 2007). In eight infants aged 2.5–12 months who had consumed a thiamin free
soy-based formula for some months, aETK were between 13.8% and 37.8% (Fattal-Valevski et al.,
2005). In the VERA (Verbundstudie Ern€ahrungserhebung und Risikofaktoren Analytik) nationally
representative survey of the German adult population (n = 2,006 adults), median thiamin intakes of
1.36 mg/day in men and 1.1 mg/day in women were associated with median aETK of 1.11 and 1.10,
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respectively (Heseker et al., 1992). In the UK National Diet and Nutrition Survey (NDNS) (n = 6,828),
mean thiamin intakes in adults were 1.44 mg/day (19–64 years) and 1.43 mg/day (≥ 65 years), and in
children 0.94 mg/day (1.5–3 years), 1.27 mg/day (4–10 years) and 1.38 mg/day (11–18 years) (Bates
et al., 2014). In blood samples obtained from 2,671 participants, mean aETK in adults was 1.12
(19–64 years) and 1.11 (≥ 65 years), and in children 1.07 (1.5–3 years), 1.10 (4–10 years) and 1.12
(11–18 years).
Interindividual variabilities of ETKA and aETK are large. In a study in Japanese subjects aged
≥ 15 years, mean ( SD) ETKA were 374  135 lg/mL erythrocytes/h (range 150–650) in 21 patients
with diagnosed beriberi compared to 461  61 lg/mL erythrocytes/h (range 250–850) in 674 control
subjects (p < 0.01) (Kuriyama et al., 1980). Measures of aETK were 34.6  18.4% (range 8–85%)
and 11.6  11.5% (range 10–55%) in the respective groups (p < 0.001). The two groups could not
be reliably separated using a single biomarker because of significant overlaps. Several factors may
affect the specificity of these assays, such as the unstability of the enzyme during sample storage
(Puxty et al., 1985), altered binding of apoenzyme and coenzyme because of the presence of
transketolase isoenzymes (Warnock et al., 1978; Baines and Davies, 1988; Talwar et al., 2000), as well
as reduced synthesis of the apoenzyme in patients with diabetes and liver disease (Talwar et al.,
2000). Prolonged thiamin deficiency also induces a reduction in the apoenzyme level so that both basal
and stimulated erythrocyte transketolase activities are low, resulting in a misleading ‘normal’ aETK
value (Bamji, 1976; Schrijver, 1991). Notable interindividual variation in the time required for formation
of fully functional holoenzyme have been reported, in particular at low TDP concentrations (Singleton
et al., 1995). The status of other nutrients which contribute to the enzyme activity (Section 2.3.6),
such as magnesium, has also been reported to affect the assay (Lonsdale, 2007).
In depletion–repletion studies, measures of basal ETKA (Ziporin et al., 1965a; Bamji, 1970; Wood
et al., 1980) and aETK (Kraut et al., 1966; Sauberlich et al., 1979; Wood et al., 1980) were found to
be sensitive to large changes in thiamin intake levels (Section 5.1.1). These markers have also been
found to respond to thiamin supplementation (Reuter et al., 1967; Asciutti-Moura et al., 1993). In
contrast, in observational cross-sectional studies in children (Jung et al., 2003), adolescents (Bailey
et al., 1994) and adults (Gans and Harper, 1991; Nichols and Basu, 1994) on their usual diet (thiamin
intake range: 1.07–1.7 mg/day), no significant relationships between thiamin intakes and measures of
ETKA and aETK were found.
The Panel notes that ETKA and aETK are sensitive markers of thiamin function and status. ETKA
decreases and aETK increases following depletion of the vitamin. A value of aETK < 1.15 (i.e. < 15%
increase in ETKA upon addition of TDP) is generally considered to reflect an adequate thiamin status.
Several factors may affect the specificity of these assays and confound their interpretation, so that
their combination with other biomarkers (Sections 2.4.1 and 2.4.3) is required to reliably assess the
thiamin status of individuals. In the usual range of intake, no relationships have been found between
thiamin intake and both ETKA and aETK.
2.4.3. Urinary excretion of thiamin
In studies using controlled diets, linear relationships between thiamin intake and 24-h urinary
excretion of free thiamin were described over a wide range of thiamin intakes (0.03 and 10 mg/day)
(Mickelsen et al., 1947; Reuter et al., 1967; Fukuwatari and Shibata, 2008; Tasevska et al., 2008;
Shibata et al., 2014). In a controlled study in seven male and six female healthy participants
consuming their usual diet for 30 days (mean  SD thiamin intake: 2.22  0.55 mg/day), large intra-
and interindividual variability in 24-h urinary excretion of thiamin was found (32.5% and 36.7%,
respectively) (Tasevska et al., 2008). In a multiple regression model controlled for body weight and
age, thiamin intake was a significant predictor of thiamin urinary excretion (adjusted r = 0.51;
p < 0.001), with almost half of the variance left unexplained. The percentage of thiamin intake
recovered in urine showed large interindividual variability (11.9–41.5%). In a longitudinal study in
which four young adults were maintained under a constant diet for 60 days (1.55 mg thiamin/day)
(van Dokkum et al., 1990), within-subject variation in urinary thiamin excretion of 11–13% was found
and the variability was similar when the results were expressed per mmol creatinine. Mean 24-h
urinary excretion ranged from 0.43 to 0.67 mg/day across subjects. The levels of carbohydrates
consumption (Elmadfa et al., 2001) (Section 2.3.6) and energy expenditure (Sauberlich et al., 1979)
(Section 2.3.7) have been found to affect urinary excretion of thiamin. Variability in thiamin absorption
(Section 2.3.3) as well as genetic variability in thiamin metabolism (Section 2.3.7) and other factors
may also influence urinary excretion of thiamin, although experimental data are lacking.
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The correlations between thiamin intake, estimated through 4-day weighted food record, and 24-h
thiamin urinary excretion were assessed in cross-sectional studies in Japanese populations (Tsuji et al.,
2010a,b, 2011). Correlations were r = 0.42 (p < 0.001) in 114 male and female children aged
10–12 years, r = 0.42 (p < 0.001) in 156 male and female adults aged 18–27 years and r = 0.62
(p < 0.001) in 37 women aged 70–84 years.
When tissues are depleted, urinary thiamin excretion is decreased. In depletion–repletion studies,
urinary excretion of the vitamin was observed to decrease progressively down to 0.04–0.07 mg/24 h
with thiamin intakes between 0.036 and 0.048 mg/MJ (0.15 and 0.20 mg/1,000 kcal) for a few weeks
(Kraut et al., 1966; Bamji, 1970; Sauberlich et al., 1979; Wood et al., 1980) (Section 5.1.1). In these
studies, thiamin urinary excretion rapidly increased upon repletion with the vitamin. In the study by
(Ziporin et al., 1965a,b), where thiamin intake was restricted to 0.009–0.015 mg/MJ (0.039–0.064 mg/
1,000 kcal) for 30 days, thiamin was not detected in urine at the end of the depletion period. The
mean amounts of thiamin metabolites (sum of pyrimidine and thiazole moieties) excreted in urine
increased from 0.588 to 0.748 mg/24 h during the control period to 0.747–0.965 mg/24 h during the
depletion period. In this study, urinary excretion below 0.03 mg/24 h persisted during the 12-day ‘low
level’ repletion period (0.046–0.052 mg/MJ (0.19–0.22 mg/1,000 kcal)), while the clinical symptoms
and biochemical impairment (decline in ETKA), which had developed during the depletion phase,
progressively disappeared. In patients with beriberi, reported urinary thiamin excretion was
< 0.015 mg/24 h (Robinson et al., 1940; Sauberlich, 1967). Urinary free thiamin excretion < 0.04 mg/24 h
may be used as an indicator of low thiamin intake associated with high risk of thiamin deficiency (WHO,
1999).
The Panel notes that 24-h urinary thiamin excretion is related to thiamin intake, particularly to
short-term intakes, in thiamin-replete individuals. However, the thiamin intake cannot reliably be
estimated from the urinary excretion of the vitamin. The determination of 24-h urinary thiamin
excretion is not a reliable marker of thiamin body stores and cannot, on its own, be used as a
biomarker of the thiamin status of individuals. In experimental studies where 24-h urinary thiamin
excretion is assessed in response to various intakes of the vitamin, a sharp increase in thiamin
excretion is considered to be indicative of the saturation of the thiamin body stores.
2.5. Effects of genotypes
Rare mutations in genes encoding thiamin transporters, ThTR-1 and ThTR-2, cause tissue-specific
(i.e. localised) deficiency of thiamin. This occurs in patients with thiamin-responsive megaloblastic
anaemia (TRMA) and patients with thiamin-responsive Wernicke’s-like encephalopathy and Leigh
syndrome (Diaz et al., 1999; Kono et al., 2009; Ortigoza-Escobar et al., 2014). The autosomal-
recessive disorder TRMA is caused by mutations in the SLC19A2 gene coding for ThTR-1 (Diaz et al.,
1999). The thiamin-responsive Wernicke’s-like encephalopathy and Leigh syndrome can be caused by
mutations in the SLC19A3 gene coding for ThTR-2 (Kono et al., 2009; Ortigoza-Escobar et al.,
2014). Mutations in the SLC25A19 gene resulting in a diminution of mitochondrial TDP transporter
have also been described. Mutations in the thiamin diphosphokinase gene (TPK1) were found to
reduce TDP concentrations in blood and muscles, and decreased the activity of TDP-dependent
enzyme complexes, especially pyruvate dehydrogenase and a-ketoglutarate dehydrogenase (Brown,
2014).
The Panel considers that, although the effect of rare mutations affecting thiamin transport and
metabolism have been characterised, no genotypes have been identified that would require
consideration with regard to the estimation of dietary reference values (DRVs) for thiamin in the
general population.
3. Dietary sources and intake data
3.1. Dietary sources
Thiamin is present in all plant (as free thiamin) and animal tissues (in phosphorylated forms). The
principal food sources of thiamin include whole grains, pulses, meat, liver and fish. Food processing
(alkaline pH, high temperatures, exposure to sulfites) contributes to significant thiamin loss (Bentreud,
1977; Clydesdale et al., 1991; Ball, 2005; Damodaran et al., 2007).
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Currently, thiamin hydrochloride and thiamin mononitrate may be added to both foods3 and food
supplements,4 and ‘thiamin monophosphate chloride’ and ‘thiamin pyrophosphate chloride’ may be also
added to food supplements.4 The thiamin content of infant and follow-on formulae and of processed
cereal-based foods and baby foods for infants and children is regulated.5
3.2. Dietary intake
EFSA estimated dietary intakes of thiamin from food consumption data available through the EFSA
Comprehensive Food Consumption Database (EFSA, 2011a), classified according to the food
classification and description system FoodEx2 (EFSA, 2011b). Data from 13 dietary surveys in nine
countries of the European Union (EU) were used. The countries included were Finland, France,
Germany, Ireland, Italy, Latvia, the Netherlands, Sweden and the UK. The data covered all age groups
from infants to adults (Appendix B).
Nutrient composition data for thiamin were derived from the EFSA Nutrient Composition Database
(Roe et al., 2013). Food composition information of Finland, France, Germany, Italy, the Netherlands,
Sweden and the UK were used to calculate thiamin intakes in these countries, assuming that the best
intake estimate would be obtained when both the consumption data and the composition data were
from the same country. For nutrient intake estimates of Ireland and Latvia, food composition data
from the UK and Germany, respectively, were used, because no specific composition data from these
countries were available. The amount of borrowed values for thiamin (i.e. values taken from other
tables or databases) varied between 15% (Germany) and 85% (Sweden) in the seven composition
databases. The food composition data available in the EFSA Nutrient Composition Database for the
respective countries include the effect of processing on thiamin content. EFSA estimates are based on
consumption of foods, either fortified or not, but without taking dietary supplements into account.
Data on infants (1–11 months old) were available from Finland, Germany, Italy and the UK. The
proportions of breast-fed infants were 58% in the Finnish survey, 40% in the German survey, 44% in
the Italian survey and 21% in the UK survey. For the Italian and German surveys, breast milk intake
estimates were derived from the number of breastfeeding events recorded per day multiplied by
standard breast milk amounts consumed on an eating occasion at different ages. For the UK survey,
the amount of breast milk consumed was either directly quantified by the mother (expressed breast
milk) or extrapolated from the duration of each breastfeeding event. In the Finnish survey, information
was limited to whether infants were breastfed or not, and the contribution of breast milk to thiamin
intakes could not be taken into consideration. The Panel notes the limitations in the methods used for
assessing breast milk consumption in infants and related uncertainties in the intake estimates for
infants (Appendices C and D).
Average thiamin intakes across countries ranged between 0.31 and 0.65 mg/day (0.11–0.21 mg/MJ)
among infants (< 1 year old), from 0.58 to 0.98 mg/day (0.12–0.21 mg/MJ) among children aged 1 to
< 3 years old, between 0.68 and 1.29 mg/day (0.10–0.21 mg/MJ) among children aged 3 to < 10 years
old, from 0.93 to 1.92 mg/day (0.11–0.20 mg/MJ) among children aged 10 to < 18 years old. The
average thiamin intake ranged between 0.88 and 1.99 mg/day (0.11–0.24 mg/MJ) among adults
(≥ 18 years old). Average daily intakes were in most studies slightly higher among males compared to
females mainly due to larger quantities of food consumed per day.
The main food groups contributing to thiamin intake were grain and grain-based products in most
population groups or food products for young population for infants or meat and meat products for
pregnant adolescents from Latvia. Beside grain and grain-based products, meat and meat products,
and milk and milk products were also important contributors to thiamin intake in adults. Differences in
main contributors to thiamin intakes between genders were minor.
EFSA intake estimates were compared with published intake estimates from the same national
surveys and age ranges (Appendix G). EFSA estimates differed at maximum around 14% from the
published values, although in several cases differences were less than 5%. Uncertainties in the
estimates of all countries may be caused by several reasons: inaccuracies in mapping food
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4 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the
Member States relating to food supplements, OJ L 183, 12.7.2002, p. 51.
5 Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive
1999/21/EC, OJ L 401, 30.12.2006, p.1. and Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-
based foods and baby foods for infants and young children, OJ L 339, 6.12.2006, p. 16–35.
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consumption data according to the FoodEx2 classification, analytical errors or errors in estimating the
thiamin content of foods in the food composition tables, the use of borrowed thiamin values from
other countries or the replacement of missing thiamin values by values of similar foods or food groups
in the thiamin intake estimation process. These uncertainties may, in principle, cause both under- and
overestimation of thiamin intake. Taking into account the many uncertainties of the thiamin intake
estimation, a difference in a magnitude of up to 15% can be considered acceptable. It is not possible
to conclude which of the intake estimates (i.e. those by EFSA or the relevant country) would be closer
to the actual thiamin intake.
4. Overview of dietary reference values and recommendations
4.1. Adults
The German-speaking countries (D-A-CH, 2015) used aETK (< 15%) and urinary thiamin excretion
(> 66 lg/day) as the criteria to set DRVs for thiamin (Finglas, 1993; Bemeur and Biutterworth, 2014).
They mentioned data on deficiency symptoms in relation to a thiamin intake of 0.05 mg/MJ during
2–8 weeks (Williams et al., 1942; Foltz et al., 1944; Wood et al., 1980), and on adequate ETKA with
marginal urinary thiamin excretion at a thiamin intake of 0.07 mg/MJ (Sauberlich et al., 1979). Both
ETKA and urinary thiamin excretion were adequate at a thiamin intake of 0.11 mg/MJ (Foltz et al.,
1944; Hathaway and Strom, 1946). They considered this intake as the AR for adults. Considering a
coefficient of variation of 10%, energy requirements, and data on balance studies and tissue
saturation with thiamin (Melnick, 1942), PRIs for adults ranging between 1.0 (women) and 1.3 (men
aged 19–25 years) mg/day were set.
For the Nordic Nutrition Recommendations (NNR) 2012, the Nordic countries related the
requirement for thiamin to the energy intake (Nordic Council of Ministers, 2014). They considered that
data on thiamin intake and health outcomes (Balk et al., 2006; Kabat et al., 2008; Pelucchi et al.,
2009; Lu’o’ng and Nguyen, 2011; Key et al., 2012) could not be used to set DRVs. The same reference
values as previously published were kept, i.e. an AR for adults of 0.10 mg/MJ (corresponding to
0.9 mg/day for women and 1.2 mg/day for men). The recommended intake (RI) was set at 0.12 mg/MJ,
and varied between 1.0 (women aged 61 years and over) and 1.4 (men aged 18–30 years) when
expressed in mg/day. They noted that thiamin utilisation is impaired among older adults (Nichols and
Basu, 1994). A lower intake level of 0.05 mg/MJ, corresponding to 0.5 mg/day for women and 0.6 mg/day
for men, was set based on clinical signs of deficiency observed at intakes below 0.5 mg/day (0.05 mg/MJ)
(Sauberlich et al., 1979; WHO/FAO, 2004). When planning diets with energy intakes lower than 8 MJ/day,
a thiamin intake of at least 0.8, or 1.0 mg/day in older adults, was recommended.
The World Health Organization/Food and Agriculture Organization (WHO/FAO, 2004) mentioned the
controlled depletion–repletion study by Sauberlich et al. (1979) that suggested an intake of 0.07 mg/MJ
as the requirement for thiamin. They also mentioned another study indicating signs of deficiency below
this intake (Wood et al., 1980), a study in adults that suggested a requirement of 1.0 and 1.2 mg/day
for women and men, respectively (Anderson et al., 1985), and data on TDP and aETK in older adults
(Hoorn et al., 1975; Nichols and Basu, 1994). The WHO/FAO proposed a recommended nutrient intake
of 1.1 and 1.2 mg/day for women and men, respectively.
Afssa (2001) mentioned the depletion–repletion study from (Sauberlich et al., 1979) and other data
on ETKA (Kraut et al., 1966; Reuter et al., 1967; Anderson et al., 1986) and thiamin excretion in urine.
Referring to the previous DRV for thiamin set in 1992, i.e. about 0.13 mg/MJ, and considering the
revised French reference values for energy, Afssa set a PRI for thiamin of 1.3 mg/day for men (for an
energy intake of 9.2 MJ/day) and 1.0 mg/day for women (for an energy intake of 7.5 MJ/day), also
noting that the thiamin intake should not be below 1 mg/day. Afssa also set a PRI of 1.2 mg/day for
adults aged 75 years and over.
The Health Council of the Netherlands (2000) considered a study by Horwitt et al. (1948), which
showed that clinical signs of deficiency in adults were observed at a thiamin intake below 0.045 mg/MJ.
The Council also considered intervention or observational studies in younger adults measuring urinary
excretion of thiamin or aETK (Melnick, 1942; Ziporin et al., 1965b; Reuter et al., 1967; Bamji, 1970;
Henshaw et al., 1970; Sauberlich et al., 1979; Wood et al., 1980; Anderson et al., 1986). For the age
range 19–50 years, the Council concluded that the AR was about 0.07–0.08 mg/MJ for men and
0.09 mg/MJ for women. Based on an energy intake of 11.2 MJ/day for men and 8.5 MJ/day for
women derived from the national food consumption survey (Hulshof et al., 1998), the ARs were
0.84 mg/day for men and 0.77 mg/day for women, averaged to an AR of 0.8 mg/day for both sexes,
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and the PRI was set at 1.1 mg/day for adults. For older adults aged 51 years and over, the Council
considered several intervention or observational studies on thiamin intake and status (thiamin urinary
excretion or aETK) (Oldham, 1962; Markkanen et al., 1969; Bowles, 1979; DHSS, 1979; Schrijver
et al., 1985; Hoofdgroep Voeding en Voedingsmiddelen TNO, 1986; van der Wielen et al., 1994). For
this age group, the Council set an AI of 1.1 mg/day.
The US Institute of Medicine (IOM, 1998) derived estimated average requirements (EARs) and
recommended daily allowances (RDAs) for adults on the basis of data from 11 metabolic studies on
young men and women that used ETKA, urinary excretion and other indicators of thiamin status
(Elsom et al., 1942; Foltz et al., 1944; Horwitt et al., 1948; Ziporin et al., 1965b; Kraut et al., 1966;
Reuter et al., 1967; Bamji, 1970; Henshaw et al., 1970; Sauberlich et al., 1979; Wood et al., 1980;
Anderson et al., 1986). The IOM considered that results from these studies suggest that the AR is at
least 0.07 mg/MJ or 0.8 mg/day, and that at an intake above 1.0 mg/day, urinary thiamin excretion is
‘normal’ and ETKA is almost ‘normal’. The IOM noted the uncertainty on the dietary intake assessment
of two studies (Henshaw et al., 1970; Anderson et al., 1986) and focused on the controlled depletion–
repletion study by Sauberlich et al. (1979). For older adults, the IOM noted that limited evidence
suggests that the requirements may be higher in older adults than in younger adults (Oldham, 1962;
Pekkarinen et al., 1974; Hoorn et al., 1975; O’Rourke et al., 1990; Nichols and Basu, 1994; Wilkinson
et al., 1997). The IOM decided to apply the same reference values as for younger adults. The IOM set
an EAR for thiamin of 1.0 mg/day for men and 0.9 mg/day for women (i.e. a 10% lower EAR for
women based on body size and energy requirements). RDAs were set at 1.2 and 1.1 mg/day,
respectively, by applying a coefficient of variation of 10%.
The SCF (1993) considered that thiamin is involved in energy-yielding metabolism, in particular
carbohydrate metabolism, and related the requirements for thiamin to energy intake. Although the SCF
noted that the maximum ETKA and the saturation of the enzyme with its coenzyme are obtained for a
thiamin intake of 0.140–0.190 mg/MJ (Brin, 1964), the SCF did not consider this to be a suitable
indicator to derive a PRI for thiamin. The SCF noted that clinical signs of deficiency are observed with
an intake of less than 0.03 mg/MJ, that a long-term intake of 0.045 mg/MJ induced a decline in
urinary excretion of thiamin down to 0.015 mg/day after 20 months without signs of deficiency, but
with an impairment of metabolism of a glucose test dose after 30 months (Horwitt et al., 1948;
Horwitt and Kreisler, 1949). The SCF also noted that an intake of 0.050 mg/MJ maintained urinary
excretion of thiamin above 0.015 mg/day in depletion–repletion studies and that an intake of
0.072 mg/MJ maintained a ‘normal’ aETK (Williams et al., 1943; Sauberlich et al., 1979). The SCF
considered 0.072 mg/MJ as the AR. Applying a coefficient of variation of 20%, the SCF set a PRI at
0.10 mg/MJ. The LTI was set at 0.050 mg/MJ. The SCF considered that thiamin requirement
expressed in lg/MJ was the same for men and women or for younger and older adults. The PRI for
thiamin corresponded to 1.1 mg/day and 0.9 mg/day for men and women, respectively, based on
average energy expenditure of 11.3 MJ/day for men and 8.5 MJ/day for women. The SCF also
suggested a PRI of 0.8 mg/day for subjects with an energy intake of less than 8 MJ/day.
The UK COMA (DH, 1991) noted that beriberi may occur at a thiamin intake of 0.48 mg/MJ
(Williams, 1961), with urinary thiamin excretion being below 0.015 mg/day. The UK COMA also noted
that 0.4 mg/day thiamin may be the ‘absolute minimum’ at ‘low’ energy intakes (Williams et al., 1943),
although this value was not confirmed in studies in older subjects (Horwitt et al., 1948). The UK COMA
considered the depletion–repletion study from Sauberlich et al. (1979) and set the AR at 0.07 mg/MJ
and a reference nutrient intake at 0.09 mg/MJ for adults. They considered that available evidence did
not suggest different requirement between men and women (Oldham et al., 1946; Platt, 1958; Bamji,
1970; Ahmed et al., 1975; Lewis and King, 1980; Tang et al., 1989) or between younger and older
adults (Horwitt et al., 1948). Based on the AR for energy set for the UK, the reference nutrient intake
was set at 1.0 mg/day for men aged 19–50 years, 0.9 mg/day for men aged 50 years and over, and
0.8 mg/day for women. The UK COMA considered that the thiamin intake should be above 0.4 mg/day
for people on ‘very low’ energy diets. A lower reference nutrient intake was also set at 0.05 mg/MJ for
adults.
An overview of DRVs for thiamin for adults is presented in Table 1.
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4.2. Infants and children
The D-A-CH (2015) considered the AR set for adults of 0.11 mg/MJ, a coefficient of variation of
10%, and the requirements for energy of infants and children, to set the PRIs ranging from 0.4 mg/day
for infants aged 4–12 months to 1.4 mg/day for boys aged 15–19 years.
The Nordic countries (Nordic Council of Ministers, 2014) kept the same reference value for infants
as previously published, i.e. 0.10 mg/MJ, thus a value of 0.4 mg/day for infants 6–11 months. The AR
and RI for children were the same as for adults, i.e. 0.10 and 0.12 mg/MJ, respectively. RIs for
children ranged between 0.5 mg/day (1–2 years) and 1.4 mg/day (boys aged 14–17 years).
The WHO/FAO (2004) considered an average thiamin content of human milk of 0.21 mg/L
(Committee on Nutrition, 1985) and an average milk intake of infants of 0.75 L/day, which correspond
to an intake of 0.16 mg/day thiamin for breast-fed infants. The WHO/FAO also mentioned data on
blood concentration of thiamin in infants and young children (Wyatt et al., 1991) and data on thiamin
intake and status on children aged 13–14 years (Bailey et al., 1994). The recommended nutrient
intake for children ranged from 0.3 mg/day for infants aged 7–11 months to 0.9 mg/day for children
aged 7–9 years. Recommended nutrient intakes for boys and girls aged 10–18 years were the same as
for adults.
For infants, Afssa (2001) mentioned an average thiamin concentration of human milk of
0.15–0.24 mg/L and set a reference value at 0.2 mg/day. For children, the PRIs were scaled down
from the PRI for adults using average square height, and ranged from 0.4 mg/day at age 1–3 years to
1.3 mg/day in boys at age 16–19 years.
For children aged 6 months to 18 years, the Health Council of the Netherlands (2000) noted the
limited evidence (Hart and Reynolds, 1957; Bailey et al., 1994), and decided to estimate adequate
intakes (AIs) by a linear interpolation between the AI for infants aged 0–5 months and the AR for
adults. The AIs ranged from 0.2 mg/day for infants aged 6–11 months to 1.1 mg/day for children
aged 14–18 years.
For infants aged 7–12 months, the IOM (1998) compared the reference values that would be
derived from the upward extrapolation from the AI of infants aged 0–6 months, from the downward
extrapolation from the EAR of adults (by allometric scaling, using body weights to the power of 0.75
and applying growth factors), or from the thiamin content of 0.6 L of breast milk, the average milk
volume consumed, and the intake of thiamin via solid foods (Montalto et al., 1985). This last approach
was considered to provide a too high value, and the IOM set an AI at 0.3 mg/day by the downward
extrapolation from adult EARs. For setting RDAs for children and adolescents aged 9–18 years, the
IOM mentioned studies in children older than 13 years that investigated thiamin urinary excretion or
erythrocyte transketolase activity (Hart and Reynolds, 1957; Dick et al., 1958; Bailey et al., 1994), but
did not consider these studies as sufficient evidence. For all children, the IOM derived EARs by the
downward extrapolation from adult EARs (by allometric scaling, using body weights to the power of
0.75 and applying growth factors) and RDAs by applying a coefficient of variation of 10%.
Table 1: Overview of dietary reference values for thiamin for adults
D-A-CH
(2015)
NCM
(2014)
WHO/FAO
(2004)
Afssa
(2001)
NL
(2000)
IOM
(1998)
SCF
(1993)
DH
(1991)
Age (years) 19–25 18–30 ≥ 19 19–74 19–50 ≥ 18 ≥ 18 19–49
DRV men (mg/day) 1.3 1.4 1.2 1.3 1.1 1.2 1.1 1.0
DRV women (mg/day) 1.0 1.1 1.1 1.1 1.1 1.1 0.9 0.8
Age (years) 25–65 31–60 – ≥ 75 ≥ 51 – – ≥ 50
DRV men (mg/day) 1.2 1.3 – 1.2 1.1(a) – – 0.9
DRV women (mg/day) 1.0 1.1 – 1.2 1.1(a) – – 0.8
Age (years) ≥ 65 ≥ 61 – – – – – –
DRV men (mg/day) 1.1 1.2 – – – – – –
DRV women (mg/day) 1.0 1.0 – – – – – –
Afssa: Agence francaise de securite sanitaire des aliments; D-A-CH: Deutschland–Austria–Confoederatio Helvetica; DH:
Department of Health; DRV: dietary reference value; FAO: Food and Agriculture Organization; IOM: US Institute of Medicine of
the National Academy of Sciences; NCM: Nordic Council of Ministers; NL: Health Council of the Netherlands; SCF: Scientific
Committee for Food; WHO: World Health Organization.
(a): adequate intake.
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The SCF (1993) concluded that the requirement for thiamin expressed in lg/MJ does not differ
between children and adults, thus set the same AR and PRI in lg/MJ. Expressed in mg/day after
calculation considering energy intake, the PRI ranged between 0.3 (infants aged 6–11 months) and
1.2 (boys aged 15–17 years) mg/day.
The UK COMA (DH, 1991) estimated the reference nutrient intake for infants to be 0.07 mg/MJ
considering an average thiamin concentration of 0.16 mg/L in breast milk and a daily breast milk
intake of 850 mL/day (0.05 mg/MJ) (DHSS, 1977), with an increase in the breast milk thiamin
concentration during the first 6 weeks post-partum (Nail et al., 1980). For children, the UK COMA
considered thiamin intake during the first year of life in the USA without signs of deficiency (0.07–
0.16 mg/MJ) (Beal, 1955) and thiamin intake of 0.06–0.09 mg/MJ associated with normal thiamin
excretion in girls aged 7–9 years (Boyden and Erikson, 1966). They also refer to a study in boys aged
14–17 years (Dick et al., 1958), which suggested that their minimum requirement was 1.41  0.2 mg/day
or 0.09  0.01 mg/MJ (0.38  0.06 mg/1,000 kcal). The UK COMA set for children the same
reference nutrient intake of 0.09 mg/MJ as for adults. Based on the AR for energy for UK, reference
nutrient intakes in children ranged from 0.2 mg/day at age 7–9 months to 1.1 mg/day in boys aged
15–18 years.
An overview of DRVs for thiamin for infants and children is presented in Table 2.
4.3. Pregnancy and lactation
The D-A-CH (2015) considered the same AR of 0.11 mg/MJ (0.45 mg/1,000 kcal) as for non-
pregnant women, a coefficient of variation of 10% and the increased energy requirement during the
second and third trimesters of pregnancy or during lactation, to set the PRIs of 1.2 (second trimester)
and 1.3 (third trimester) mg/day for pregnant women and 1.3 mg/day for lactating women.
The Nordic Countries (Nordic Council of Ministers, 2014) followed the approach of the IOM and
considered an additional intake of 0.4 mg/day during pregnancy and 0.5 mg/day during lactation, thus
a total RI of 1.5 and 1.6 mg/day for pregnant and lactating women, respectively.
Table 2: Overview of dietary reference values for thiamin for infants and children
D-A-CH
(2015)
NCM
(2014)
WHO/FAO
(2004)
Afssa
(2001)
NL
(2000)
IOM
(1998)
SCF
(1993)
DH
(1991)
Age (months) – – – – – – – 7–9
DRV (mg/day) – – – – – – – 0.2
Age (months) 4–12 6–11 7–12 Infants 6–11 7–12 6–11 10–12
DRV (mg/day) 0.4 0.4 0.3 0.2 0.2(a) 0.3(a) 0.3 0.3
Age (years) 1–4 1–2 1–3 1–3 1–3 1–3 1–3 1–3
DRV (mg/day) 0.6 0.5 0.5 0.4 0.3(a) 0.5 0.5 0.5
Age (years) 4–7 2–5 4–6 4–6 4–8 4–8 4–6 4–6
DRV (mg/day) 0.7 0.6 0.6 0.6 0.5(a) 0.6 0.7 0.7
Age (years) 7–10 6–9 7–9 7–9 9–13 7–10 7–10
DRV boys (mg/day) 0.9 0.9 0.9 0.8 0.8(a) 0.8 0.7
DRV girls (mg/day) 0.8 0.9 0.9 0.8 0.8(a) 0.8 0.7
Age (years) 10–13 10–13 10–18 10–12 14–18 9–13 11–14 11–14
DRV boys (mg/day) 1.0 1.1 1.2 1.0 1.1(a) 0.9 1.0 0.9
DRV girls (mg/day) 0.9 1.0 1.1 1.0 1.1(a) 0.9 0.9 0.7
Age (years) 13–15 14–17 – 13–19 – 14–18 15–17 15–18
DRV boys (mg/day) 1.2 1.4 – 1.3 – 1.2 1.2 1.1
DRV girls (mg/day) 1.0 1.2 – 1.1 – 1.0 0.9 0.8
Age (years) 15–19 – – – – – – –
DRV boys (mg/day) 1.4 – – – – – – –
DRV girls (mg/day) 1.1 – – – – – – –
Afssa: Agence francaise de securite sanitaire des aliments; D–A–CH: Deutschland–Austria–Confoederatio Helvetica; DH:
Department of Health; DRV: dietary reference value; FAO: Food and Agriculture Organization; IOM: US Institute of Medicine of
the National Academy of Sciences; NCM: Nordic Council of Ministers; NL: Health Council of the Netherlands; SCF: Scientific
Committee for Food; WHO: World Health Organization.
(a): adequate intake.
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In line with the approach by IOM (1998), the WHO/FAO (2004) proposed an additional intake of
0.3 mg/day during pregnancy and an additional intake of 0.4 mg/day during lactation, to be added to
the recommended nutrient intake for non-pregnant non-lactating women, thus recommended nutrient
intakes of 1.4 and 1.5 mg/day for pregnant and lactating women, respectively.
Afssa (2001) mentioned human and animal data on urinary and blood biomarkers of thiamin status
during pregnancy, especially during the third trimester (Heller et al., 1974; Dostalova et al., 1988;
Roth-Maier et al., 1990; Icke and Nicol, 1994). Afssa set a reference value of 1.8 mg/day for pregnant
women. Afssa noted that thiamin content in breast milk is related to thiamin status of the mother
(Thomas et al., 1980), that its secretion in breast milk is on average 0.2 mg/day (Nail et al., 1980) and
that energy intake increases during lactation. Afssa set a reference value of 1.8 mg/day for lactating
women.
The Health Council of the Netherlands (2000) mentioned studies concerning thiamin requirement
during pregnancy (Reuter et al., 1967; Sauberlich, 1978; van den Berg and Bruinse, 1983), which
could not be used to set reference values. The Council noted the increased energy intake and the
growth of maternal and fetal tissues during pregnancy, and estimated the additional requirement to be
0.2 mg/day thiamin. The Council proposed for pregnancy a total AR of 1.0 mg/day and a PRI of
1.4 mg/day. During lactation, the Council considered a secretion of thiamin in breast milk of 0.16 mg/day
based on a milk production of 0.8 L/day and an average thiamin concentration in breast milk of 0.2 mg/L
(Fomon and McCormick, 1993), and the increased energy requirements of the mothers. After rounding,
the Council thus added 0.4 mg/day to the AR of non-lactating women, and set a total AR of 1.2 mg/day
and a total PRI of 1.7 mg/day during lactation.
The IOM (1998) reported studies in pregnant and non-pregnant women (Toverud, 1940; Lockhart
et al., 1943; Hathaway and Strom, 1946; Oldham et al., 1946, 1950; Datjm et al., 1948; Slobody
et al., 1949; Tripathy, 1968; Chong and Ho, 1970; Heller et al., 1974). They could not be used to set
DRVs for pregnancy. The IOM set the EARs for pregnant women considering the increased growth in
maternal and fetal compartments (20%) and in energy utilisation (10%), leading to a requirement of
0.3 mg/day after rounding, to be added to the EAR for non-pregnant women. The total EARs for the
second and third trimesters of pregnancy were set at 1.2 mg/day. The RDA of 1.4 mg/day was derived
using a coefficient of variation (CV) of 10%. For lactating women, taking into account the average
volume of milk intake of 0.78 L/day (Hofvander et al., 1982; Chandra, 1984; Neville et al., 1988; Allen
et al., 1991; Butte and King, 2002) and an average thiamin content in breast milk of 0.21 mg/L
(Committee on Nutrition, 1985), the IOM estimated that 0.16 mg/day of thiamin is transferred in the
milk. According to the IOM, these 0.16 mg/day, as well as 0.1 mg/day (to cover the energy cost of
milk production) should be added to the EAR for non-pregnant, non-lactating women. The EAR for
lactating women was set at 1.2 mg/day, after rounding. The RDA of 1.4 mg/day was derived using a
CV of 10%.
The SCF (1993) and the UK COMA (DH, 1991) considered the PRIs set for adults to be sufficient to
cover the period of pregnancy and lactation, thus considered that there is no need to increase the PRI
for thiamin (expressed in mg/MJ) during a normal pregnancy and that the loss of thiamin in human
milk would be compensated by the higher energy intake during lactation. Calculating the PRIs in mg/day
considering the increased energy intake during pregnancy and lactation, the PRI set by the SCF was
1.0 mg/day from the 10th week of pregnancy, and 1.1 mg/day for lactation. Considering available data
in pregnant women (Oldham et al., 1950; Bagchi and Bose, 1962), and a secretion of 0.14 mg/day of
thiamin in breast milk (for a content of 0.16 mg/L and a daily volume of 850 mL), the UK COMA (DH,
1991) set the reference nutrient intake for pregnant or lactating women at 0.09 mg/MJ, as for other
women. Expressed in mg/day and considering the AR for energy in the UK, this would lead to an
additional 0.1 mg/day thiamin during the last trimester of pregnancy, and an additional 0.2 mg/day
thiamin during lactation.
An overview of DRVs for thiamin for pregnant or lactating women is presented in Table 3.
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5. Criteria (endpoints) on which to base dietary reference values
5.1. Indicators of thiamin requirement
5.1.1. Depletion–repletion studies
A number of depletion–repletion studies have assessed changes in ETKA/aETK and urinary
excretion of thiamin in response to controlled dietary intake of thiamin. The Panel considers that taken
together these are suitable biomarkers for deriving the requirement for thiamin (Sections 2.4.2 and
2.4.3). The Panel also considers that there is a positive relationship between thiamin requirement and
energy requirement (Section 2.3.7). Therefore, thiamin intakes are expressed per MJ (per 1,000 kcal)
for the assessment.
Williams et al. (1942) reported that a thiamin intake of 0.052 mg/MJ (0.22 mg/1,000 kcal) for up
to 6 months in two healthy subjects caused anorexia and a marked impairment of mental and physical
health. In another study on two healthy subjects, an intake of 0.042 mg/MJ (0.175 mg/1,000 kcal) for
3 months was accompanied by the development of unspecific clinical signs suggestive of thiamin
deficiency (Williams et al., 1943).
One study involved eight healthy young men (age not reported) who were hosted in a metabolic
ward for 51 days and received a diet providing 11.71 MJ/day (2,800 kcal/day) and 0.110–0.180 mg
thiamin/day (Ziporin et al., 1965a,b). The study was divided into three parts: a control period (thiamin
intake 1.71–1.78 mg/day (~0.150 mg/MJ) for 9 days), a depletion period (0.110–0.180 mg/day
(0.009–0.015 mg/MJ) for 30 days) and a ‘low level’ repletion period (0.540–0.610 mg/day (0.046–0.052
mg/MJ) for 12 days). Physical activity was performed ad libitum with attempts to minimise inter- and
intra-individual variations. During depletion, unspecific subjective symptoms (e.g. general malaise,
headache, nausea) and physical symptoms (sinus tachycardia at rest (3/8), diminution of muscle
strength (2/8) and tendon reflexes (4/8)) developed gradually in five subjects, while three subjects
remained asymptomatic throughout the study. Physical symptoms disappeared within 1 week of
thiamin repletion, while subjective symptoms persisted for 2 weeks, and then gradually disappeared. A
progressive decline in ETKA to about 75% of the baseline value was observed during the depletion
period, while ETKA returned to baseline value after 1 week of repletion. The mean ( SD) urinary free
thiamin excretion was 0.283  0.071 mg/24 h at the end of the control period and decreased to
undetectable levels by 18 days of depletion. From then to the end of depletion, urinary excretion of
thiamin metabolites (sum of pyrimidine and thiazole moieties) ranged from 0.884  0.217 to
0.913  0.224 mg/24 h. During repletion, small amounts (0.003–0.013 mg/24 h) of free thiamin were
detected in urine samples, although not in all subjects. The authors assumed that continued excretion
of thiamin metabolites during the depletion period indicates that tissue thiamin is used for metabolic
purposes, and that metabolites represent a measure of depletion of the vitamin body stores. The
authors defined thiamin requirement as the amount of thiamin which would at least equal the amount of
metabolites excreted when there is no intact thiamin in the urine: (1) by subtracting 0.160 mg of thiamin
ingested daily with the diet from a mean thiamin metabolites output of 0.913 mg/24 h during depletion, a
thiamin requirement of 0.753 mg/day, corresponding to 0.064 mg/MJ (0.27 mg/1,000 kcal), was
calculated; (2) by considering the total amount of thiamin metabolites excreted, a thiamin requirement of
0.913 mg/day, corresponding to 0.078 mg/MJ (0.33 mg/1,000 kcal), was proposed. The Panel notes that
in this study the amount of thiamin required daily to replace the thiaminmetabolites was 0.064–0.078 mg/MJ
(0.27–0.33 mg/1,000 kcal).
Table 3: Overview of dietary reference values for thiamin for pregnant or lactating women
D-A-CH (2015)
NCM
(2014)
WHO/FAO
(2004)
Afssa
(2001)
NL
(2000)
IOM
(1998)
SCF
(1993)
DH
(1991)
DRV pregnancy
(mg/day)
1.2 (2nd trimester)
1.3 (3rd trimester)
1.5 1.4 1.8 1.4 1.4 1.0 0.9
DRV lactation (mg/day) 1.3 1.6 1.5 1.8 1.7 1.4 1.1 1.0
Afssa: Agence francaise de securite sanitaire des aliments; D-A-CH: Deutschland–Austria–Confoederatio Helvetica; DH:
Department of Health; DRV: dietary reference value; FAO: Food and Agriculture Organization; IOM: US Institute of Medicine of
the National Academy of Sciences; NCM: Nordic Council of Ministers; NL: Health Council of the Netherlands; SCF: Scientific
Committee for Food; WHO: World Health Organization.
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In another study, six healthy adults (four men, two women, aged 22–27 years) were on a diet
containing 0.035–0.239 mg thiamin/MJ (0.15–1 mg/1,000 kcal) for various time intervals during
9–10 months (Kraut et al., 1966). ETKA and urinary thiamin excretion were measured. A decrease of
thiamin intake from 0.13 to 0.22 mg/MJ (0.54–0.92 mg/1,000 kcal) to 0.05–0.03 mg/MJ (0.15–0.21
mg/1,000 kcal) was associated with a drop in ETKA, and an increase in thiamin intake in the next
study period to 0.07–0.09 mg/MJ enhanced ETKA up to levels similar to baseline. Urinary excretion of
thiamin was in the range of 0.053–0.507 mg/24 h. Urinary thiamin excretion was linearly related to
dietary thiamin intake (r = 0.9 calculated based on presented data). Subjects had a decreased physical
capacity in the bicycle ergometer tests, and one subject complained about lack of concentration and
muscle pain with rapid walking over short distances. Complaints disappeared with a thiamin intake of
0.074 mg/MJ. A thiamin intake of 0.07–0.09 mg/MJ resulted in enhanced urinary thiamin excretion,
and a further rise in thiamin intake to 0.13–0.19 mg/MJ was associated with a sharp increase in
urinary thiamin excretion, suggesting that an intake of 0.07–0.09 mg/MJ may represent the thiamin
requirement. Measures of ETKA associated with a thiamin intake of 0.13–0.19 mg/MJ were similar to
those observed with a thiamin intake of 0.07–0.09 mg/MJ. The Panel notes that maximum ETKA was
observed at a daily thiamin intake of 0.17–0.22 mg/MJ. The Panel notes that in this study the
measurement of different products to assess ETKA made the results difficult to interpret.
Bamji (1970) measured ETKA and urinary thiamin excretion (expressed in lg/g creatinine) in eight
healthy Indian volunteers (four men, four women; age not reported) consuming an experimental diet
providing 0.024 mg thiamin/MJ (0.1 mg/1,000 kcal) for 2–3 weeks (period I), and thereafter
0.048 mg/MJ (0.2 mg/1,000 kcal) and 0.096 mg/MJ (0.4 mg/1,000 kcal) for two 10-day periods
(period II and III). An intake of 0.024 mg/MJ for 7 days resulted in ETKA decrease by 15%, and after
21 days by 32% in men and by 50% in women. A thiamin intake of 0.048 mg/MJ was associated with
EKTA increase to about 88% of the baseline and at intake of 0.096 mg/MJ, EKTA activity was not
lower than the baseline value. In men, a continuous decrease in urinary thiamin excretion was
observed until about 25% of the baseline values at the end of period I, followed by an increase in
periods II (up to 50% of the baseline values) and III (up to 140% of baseline values). In women,
urinary thiamin excretion decreased to about 35% of the baseline values at the end of period I, with
no apparent change in period II (about 30% of baseline values) and an increase to up to 82% of
baseline values at the end of period III. In order to estimate thiamin requirement, the logarithm of
dietary thiamin intake was plotted against ETKA or against urinary thiamin excretion. Tangents were
drawn to the slopes and the points of insertion of these tangents were used to assess the requirement
as the turning points at which ETKA had reached a plateau or a sharp increase in thiamin urinary
excretion occurred. Based on urinary thiamin excretion, a requirement for thiamin of 0.063 mg/MJ
(0.26 mg/1,000 kcal) for women and 0.075 mg/MJ (0.31 mg/1,000 kcal) for men was estimated.
Based on ETKA, a thiamin requirement of 0.051 mg/MJ (0.21 mg/1,000 kcal) for women and
0.080 mg/MJ (0.34 mg/1,000 kcal) for men was derived. The Panel notes that these values were
estimated from modelling data on a small number of subjects and uncertainties related to these
estimates cannot be assessed from the paper. The Panel notes that in this study, a level of 0.048 mg
thiamin/MJ was insufficient to restore baseline ETKA, while a level of 0.096 mg/MJ was associated with
a sharp increase in urinary excretion.
In the study by Sauberlich et al. (1979), seven healthy men (age not reported) received a diet free
of thiamin for 14 days (depletion period, I). They were then divided into two groups with different
levels of energy intake (group A: 11.72 MJ/day (2,800 kcal/day) and group B: 15.06 MJ/day
(3,600 kcal/day)). For successive periods of 11–14 days, subjects received controlled amounts of
thiamin of 0.39 (period II), 0.56 (period III), 0.84 (period IV) and 0.84 or 1.08 mg/day (period V),
corresponding to 0.033, 0.048, 0.072 and 0.072 mg/MJ for group A (n = 3), and 0.026, 0.038, 0.055
and 0.072 mg/MJ for group B (n =4), respectively. Finally, an ad libitum diet containing > 2 mg
thiamin/day (> 0.143 mg/MJ) was provided to both groups (period VI). Constant body weight of the
subjects was maintained by adjustment of scheduled daily physical activity and exercise. During
periods I (no thiamin) and II (lowest thiamin intake), a progressive decline in urinary thiamin excretion
was observed to about 0.025 mg/24 h in both groups. In periods III and IV, urinary thiamin excretion
rose gradually in both groups but urinary thiamin excretion was significantly lower in group B than in
group A. There was no difference in urinary thiamin excretion in period V, when both groups received
0.072 mg/MJ (mean  SD: 0.088  0.009 and 0.090  0.023 mg/24 h in groups A and B,
respectively). Urinary thiamin excretion similar to baseline excretion was reached at the end of the
study (0.258  0.010 and 0.302  0.076 mg/24 h in groups A and B, respectively). Mean baseline
aETK level was about 1.02 for group A and 1.03 for group B. In both groups, similar increases in
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mean aETK were observed during periods I–III, up to above 1.35. In group A, mean aETK decreased
to 1.12 in period IV and 1.03 in period V, while in group B the respective figures were 1.22 and 1.07.
This indicates that an intake of 0.055 mg/MJ for 11 days was insufficient to restore adequate thiamin
status, while an intake of 0.072 mg/MJ was associated with an adequate status of the vitamin
(aETK ≤ 1.15, see Section 2.4.2). During period VI (ad libitum), mean aETK in both groups was about
1.03. The Panel notes that, contrary to group A, a daily intake of 0.84 mg thiamin/day failed to restore
normal aETK in group B, which indicates an increased requirement for thiamin when energy
requirement is increased. The Panel notes that aETK returned to normal level (mean aETK about 1.03–
1.07) at a thiamin intake of 0.072 mg/MJ and was associated with urinary thiamin excretion of about
0.09 mg/24 h. On an ad libitum diet providing > 0.14 mg thiamin/MJ, a sharp increase (to about
0.3 mg/24 h) of urinary thiamin excretion occurred, while only slight changes in aETK were noted.
5.1.2. Observational studies
Several observational studies assessed thiamin intake, through dietary questionnaires, and
biomarkers of thiamin status in adult populations, particularly older populations.
Using a 7-day dietary recall questionnaire, Anderson et al. (1986) reported a mean thiamin intake
of about 0.12 mg/MJ (0.5 mg/1,000 kcal) in a group of 11 male and female adults (25–75 years) with
aETK > 1.15 compared to about 0.14 mg/MJ (0.6 mg/1,000 kcal) in 31 men and women with
aETK < 1.15. High prevalence (> 40%) of aETK > 1.15 were found in two studies which involved older
subjects (≥ 65 years) with a mean thiamin intake around 0.19 mg/MJ (0.8 mg/1,000 kcal) (30 men
and 30 women), assessed by a 3-day food record (Nichols and Basu, 1994) and 0.12 mg/MJ (0.5 mg/
1,000 kcal) (80 women), assessed by four 24-h recall questionnaires (Smidt et al., 1991). The
Panel notes that these studies included subjects with health issues and assessed a single biomarker.
In a study in subjects selected to be free of apparent disease, aETK < 15% and similar erythrocyte
total thiamin concentrations were found in groups of younger (19–37 years, n = 14) and older (70–82
years, n = 10) people with a thiamin intake around 0.17 mg/MJ (0.7 mg/1,000 kcal), assessed by a 3-day
weighted record (O’Rourke et al., 1990). Lower ETKA was found in the older compared to the younger
subjects (1,287 (1,163–1410) mU/g Hb vs 1,482 (1,320–1,645) mU/g Hb; p < 0.05). The authors
noted that the actual thiamin intakes were likely to be lower than the estimated intakes as they were
derived from food tables that might overestimate the true thiamin content of food by up to 30%.
The Panel notes the methodological limitations of these studies. The Panel considers that these
studies do not provide data for deriving DRVs for thiamin in adults. The Panel also considers that these
studies do not provide evidence for a different dietary requirement of thiamin in older compared to
younger adults.
5.1.3. Conclusions on indicators of thiamin requirements in adults
The Panel considers that results from the controlled experiment by Sauberlich et al. (1979) indicate
a positive relationship between thiamin requirement and energy requirement.
The Panel notes that thiamin intake of 0.009–0.014 mg/MJ for about a week resulted in significant
reduction in the urinary thiamin excretion and ETKA associated with the development of some
unspecific clinical symptoms of thiamin deficiency (Ziporin et al., 1965a,b). The Panel also notes that
thiamin intakes of 0.042–0.052 mg/MJ for some months were associated with clinical symptoms
suggestive of thiamin deficiency (Williams et al., 1942, 1943).
The Panel considers that the study by Sauberlich et al. (1979) indicates a thiamin requirement of
0.072 mg/MJ for adult men because this thiamin intake was associated with low urinary thiamin
excretion (around 0.09 mg/day) and aETK indicative of an adequate thiamin status (< 15%). The
Panel also notes that, in this study, increasing the thiamin intake from 0.072 to ≥ 0.14 mg/MJ was
associated with a sharp increase in urinary thiamin excretion and only slight changes in transketolase
activity, indicating tissue saturation. The Panel notes that the depletion–repletion study by Kraut et al.
(1966) supports this value. In this study, ETKA was restored with an intake of thiamin of 0.07–0.09
mg/MJ, while urinary thiamin excretion sharply increased with a thiamin intake of 0.13–0.19 mg/MJ
without further change in ETKA. Based on similar criteria, the study by Bamji (1970) indicates that
mean thiamin requirement is higher than 0.048 mg/MJ and lower than 0.096 mg/MJ, which is
consistent with these findings. The Panel notes that these studies were performed in a small number of
subjects and mean values of dietary thiamin intake, ETKA/aETK and urinary thiamin excretion were
used to assess thiamin requirement.
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The Panel also notes that maximum ETKA was observed at a daily thiamin intake of 0.17–0.22 mg/MJ
(Kraut et al., 1966). The Panel considers that the biological significance of maximal stimulation of ETKA
and whether it is required for adequate body function is not known.
5.1.4. Infants and children
Some studies attempted to estimate thiamin requirement of infants (Holt et al., 1949) and children
(Dick et al., 1958) based on the changes in urinary excretion of thiamin in response to controlled
amounts of dietary thiamin. In these studies, the level of thiamin intake associated with ‘minimal’
urinary thiamin excretion was used as a criterion to define thiamin requirement. The Panel notes that a
single biomarker was used in these studies, which does not reliably reflect thiamin status.
In an observational study in 19 boys and 35 girls aged 13–14 years in the UK, Bailey et al. (1994)
assessed thiamin intake, based on 7-day weighed record and direct analysis of duplicate diets, and
ETKA, aETK and total erythrocytes thiamin. Mean analysed thiamin intakes were 1.52 mg/day in girls
and 1.95 mg/day in boys, corresponding to 0.88 mg/1,000 kcal in both groups. The average 7-day
calculated thiamin intake was significantly lower than analysed intakes for both sexes. On an individual
basis, calculated intakes ranged from 30% to 143% of corresponding analysed values. Mean (range)
aETK were 1.07 (0.86–1.45) in girls and 1.05 (0.69–1.36) in boys. Mean (range) ETKA were
89.66 (54.5–165.74) mU/g Hb in girls and 90.08 (58.33–140.62) mU/g Hb in boys. Mean (range) total
thiamin concentrations in erythrocytes were 226.8 (101.0–949.9) nmol/L in girls and 206.1 (119.7–
445.7) nmol/L in boys. Overall, 30.8% of children had aETK ≥ 1.15, while 1.9% of children had an
analysed thiamin intake < 0.1 mg/MJ (0.4 mg/1,000 kcal). No correlations were found between
analysed thiamin intake and any of the markers measured. The Panel considers that no conclusion can
be drawn from this study with respect to thiamin requirement in children.
The Panel considers that there are no studies which can be used for deriving requirement for
thiamin in infants and children.
5.1.5. Pregnant and lactating women
Some observational studies in pregnant women have reported high prevalence (20–40%) of aETK
coefficient > 1.20, taken as indicative of an inadequate thiamin status (Heller et al., 1974; Vir et al.,
1980), as well as decrease in ETKA and blood thiamin concentration during pregnancy (Dirige et al.,
1978; Vir et al., 1980; Baker et al., 2002). One study found no correlations between aETK and the
length, weight and head circumference of the newborns (Dirige et al., 1978). The Panel notes that
thiamin intake was not reported in these studies and the cause (e.g. physiological changes, other
determinants) and significance of these observations in pregnant women are unknown.
Ortega et al. (2004) examined the relationship between thiamin intake (assessed using a 5-day
weighted dietary record) and aETK in 51 pregnant Spanish women (aged 18–35 years) in the third
trimester. Thiamin concentration in their mature breast milk was also measured. About 13.7% of
women had aETK > 1.25, used as a cut-off for thiamin deficiency. Women were divided between those
who had thiamin intake > or < 0.4 mg/1,000 kcal + 0.1 mg per day.6 Mean thiamin intakes of the
respective groups were 1.45  0.38 mg/day and 0.87  0.13 mg/day. When expressed on a per MJ
basis, mean thiamin intakes were similar in both groups (0.16  0.03 mg/MJ vs 0.14  0.04 mg/MJ).
Mean aETK value was significantly lower in the first than in the second group (1.01  0.19 vs
1.21  0.30, p < 0.05). In the first group, 23.7% of women had aETK > 1.15, and 53.8% in the
second group. Thiamin concentrations in mature breast milk were 157  117 lg/L and 66  19 lg/L
in the respective groups (p < 0.05). The Panel notes that data are presented in aggregated form and
that this study cannot be used to assess the level of thiamin intake which would be associated with
adequate thiamin status.
The Panel considers that the available data on the relationship between thiamin intake and
biomarkers of thiamin status in pregnancy cannot be used for deriving DRVs for thiamin in pregnancy.
There are no data on the relationships between thiamin intake and biomarkers of thiamin status in
lactating women.
6 Recommended intake for thiamin during pregnancy for the Spanish population Departamento de Nutricion, 1994. Ingestas
Diarias Recomendadas de Energia y Nutrientes para la Poblacion Espanola [Recommended Energy and Nutrient Intakes for the
Spanish Population] Departamento de Nutricion, Madrid, Spain.
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5.2. Thiamin intake and health consequences
A comprehensive search of the literature published between 1990 and 2011 was performed as a
preparatory work to this assessment in order to identify new data on relevant health outcomes upon
which DRVs for thiamin may potentially be based (El-Sohemy et al., 2012). An additional literature
search (in Pubmed) was performed to identify new data published afterwards and until September
2016 on thiamin intake and health outcomes.
The relationship between thiamin intakes and health outcomes has been investigated in
observational (case–control, cross-sectional, prospective cohort) studies, where an association between
thiamin intake and health outcomes may be confounded by uncertainties inherent in the methodology
used for the assessment of thiamin intakes and by the effect of other dietary, lifestyle or undefined
factors on the health or disease outcomes investigated. No intervention studies are available on
thiamin intake and health outcomes.
Available data on the relationship between thiamin intake and mortality (Huang et al., 2012),
nuclear cataract (Cumming et al., 2000), squamous intraepithelial cervical lesions (Hernandez et al.,
2003), glucose intolerance (Bakker et al., 1998) and premenstrual syndrome (Chocano-Bedoya et al.,
2011) are limited and therefore cannot be used to derive DRVs for thiamin.
The relationship between dietary thiamin intake and cognitive function in healthy older adults was
assessed in a review by Koh et al. (2015). Nine studies (two cohort studies and seven cross-sectional
studies) were included. Among the cohort studies, one examined the relationship between thiamin
intake and abstract reasoning and found a positive correlation (r = 0.29; p < 0.01); there was no
significant correlation between thiamin intake and visuospatial skills or nonverbal learning and memory
(La Rue et al., 1997). In the other cohort study by McNeill et al. (2011), no association was found
between thiamin intake and measures of cognitive function. Among the cross-sectional studies, five
reported a positive association between thiamin intake and measures of cognitive function (most
commonly assessed by Mini Mental State Examination) (Nes et al., 1988; Ortega et al., 1997; Lee
et al., 2001; Requejo et al., 2003; Aparicio Vizuete et al., 2010), while two found no association
(Shatenstein et al., 2007; Katsiardanis et al., 2013). The Panel notes that there is no consistent
evidence for an association between dietary intake of thiamin and cognitive function in healthy older
people.
The Panel considers that available data on thiamin intake and health outcomes are either limited or
inconsistent and cannot be used for deriving DRVs for thiamin.
5.3. Data on which to base dietary reference values
The Panel considers that data from depletion–repletion studies in adults on the amount of dietary
thiamin intake associated with aETK < 1.15 or with the restoration of normal (baseline) ETKA, without
a sharp increase in urinary thiamin excretion, can be used to estimate thiamin requirement
(Section 5.1.1). The Panel considers that thiamin requirement is related to energy requirement
(Sections 2.3.7 and 5.1.1) and decides to set DRVs on a per MJ basis. PRIs for thiamin of particular
population groups, expressed in mg/day, can be estimated based on their respective energy
requirements. The ARs for energy for various physical activity levels (PAL values) can be found in the
Scientific Opinion on Dietary Reference Values for energy (EFSA NDA Panel, 2013). The Panel notes that,
as for other nutrient reference values, DRVs for thiamin are set under the assumption that intakes of
other essential nutrients and energy are adequate.
5.4. Adults
The Panel considers that no additional scientific evidence has become available since the
assessment of the SCF in 1993 which would require to reconsider the DRVs for thiamin set at that
time. The Panel endorses the AR of 0.072 mg/MJ (0.3 mg/1,000 kcal) for all adults which was set by
the SCF on the basis of the depletion–repletion study by Sauberlich et al. (1979). The Panel notes that
the study from Sauberlich et al. (1979) involved a small number of men; however, the Panel considers
that results from other depletion–repletion studies (Kraut et al., 1966; Bamji, 1970) are in agreement
with this value. The Panel agrees on the coefficient of variation of 20% used by the SCF, to cover
uncertainties related to the distribution of thiamin requirements in the general population, and
endorses the population reference intake (PRI) of 0.1 mg/MJ (0.4 mg/1,000 kcal) proposed by the SCF
for all adults (Table 4). No new evidence has become available that the relationship between thiamin
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requirement and energy requirement differs between men and women, or between younger and older
adults. PRIs for thiamin, expressed in mg/day, are presented in Appendix H.
5.5. Infants
For infants aged 7–11 months, the Panel assumes that the relationship between thiamin
requirement and energy requirement does not differ from that of adults. Therefore, the AR and PRI,
expressed as mg/MJ, for adults are applied (Table 4). PRIs for children, expressed in mg/day, are
presented in Appendix I.
5.6. Children
For children, the Panel assumes that the relationship between thiamin requirement and energy
requirement does not differ from that of adults. Therefore, the AR and PRI, expressed as mg/MJ, for
adults are applied (Table 4). PRIs for children, expressed in mg/day, are presented in Appendix J.
5.7. Pregnancy
The Panel assumes that the relationship between thiamin requirement and energy requirement in
pregnancy does not differ from that of other adults. Therefore, the AR and PRI, expressed as mg/MJ,
for adults apply to pregnancy (Table 4). The Panel notes that the energy requirement in pregnant
women is increased by 0.29, 1.1 and 2.1 MJ/day, for the first, second and third trimesters, respectively
(EFSA NDA Panel, 2013). The PRI for thiamin of pregnant women, in mg/day, is increased compared
with that of non-pregnant women, as presented in Appendix K.
5.8. Lactation
The Panel assumes that the relationship between thiamin requirement and energy requirement in
lactating women does not differ from that of other adults. Therefore, the AR and PRI, expressed as
mg/MJ, for adults apply to lactation (Table 4). The Panel notes that the energy requirement in
lactation is increased by 2.1 MJ/day (EFSA NDA Panel, 2013). An average loss of thiamin in breast milk
of 0.15 mg/day was estimated during the first six month of lactation (Section 2.3.5.4). The
Panel considers that the extra requirement for thiamin calculated on the basis of the increased energy
requirement related to lactation covers the losses of thiamin through breast milk. The PRI for thiamin
of lactating women, in mg/day, is increased compared with that of non-lactating women, as presented
in Appendix K.
Conclusions
The Panel concludes that no new scientific data have become available that would require to
change the population reference intake (PRI) for thiamin set by the SCF in 1993. The Panel sets a PRI
for thiamin of 0.1 mg/MJ (0.4 mg/1,000 kcal) for all population groups (Table 4).
Table 4: Summary of dietary reference values for thiamin
Age PRI (mg/MJ)
7–11 months 0.1
1–3 years 0.1
4–6 years 0.1
7–10 years 0.1
11–14 years 0.1
15–17 years 0.1
≥ 18 years(a) 0.1
PRI: population reference intake.
(a): including pregnancy and lactation.
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Recommendations for research
The Panel recommends:
• studies to characterise the relationship between thiamin intake and the most informative
combination of biomarkers of thiamin status, in different life stages;
• further investigations of the dose–response relationships between thiamin intake and individual
biomarkers;
• further research on the use of erythrocyte TDP concentration as a marker of thiamin intake
and status;
• further research on the effect of diet composition (e.g. carbohydrates) on the thiamin
requirement;
• further research on the relationship between thiamin requirement and energy requirement.
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Appendix E – Minimum and maximum percentage contribution of different food groups
(FoodEx2 level 1) to thiamin intake estimates among males
Food groups Age
< 1 year 1–< 3 years 3–< 10 years 10–< 18 years 18–< 65 years 65–< 75 years ≥ 75 years
Additives, flavours,
baking and processing
aids
< 1 < 1 0–1 0–1 0 0 0
Alcoholic beverages < 1 < 1 < 1 < 1 1–2 < 1–1 < 1–1
Animal and vegetable
fats and oils
0 < 1 < 1 < 1 < 1 < 1 < 1
Coffee, cocoa, tea and
infusions
< 1–1 < 1–1 < 1–1 < 1–2 1–5 1–6 1–4
Composite dishes < 1–2 < 1–8 < 1–9 1–12 < 1–15 < 1–13 < 1–14
Eggs and egg
products
< 1 < 1–1 < 1–2 < 1–2 < 1–2 < 1–2 < 1–2
Fish, seafood,
amphibians, reptiles
and invertebrates
< 1 < 1–2 < 1–3 < 1–3 1–4 1–6 1–6
Food products for
young population
35–58 3–14 < 1–1 < 1 < 1 – –
Fruit and fruit
products
2–4 3–7 2–5 1–4 2–6 3–7 2–8
Fruit and vegetable
juices and nectars
< 1–2 1–7 3–11 2–11 1–7 1–5 1–2
Grains and grain-
based products
6–15 24–34 20–38 21–39 20–36 18–33 19–35
Human milk < 1–20 < 1–1 – – – – –
Legumes, nuts,
oilseeds and spices
< 1–4 1–6 1–6 1–5 2–6 2–7 2–6
Meat and meat
products
2–12 8–16 14–25 19–26 21–30 19–29 19–27
Milk and dairy
products
5–9 17–22 10–20 6–17 5–14 6–14 7–10
Products for non-
standard diets, food
imitates and food
supplements or
fortifying agents
< 1–1 0–1 < 1–1 < 1–1 < 1–1 < 1 < 1–1
Seasoning, sauces and
condiments
< 1–3 < 1–2 < 1–3 < 1–3 < 1–3 < 1–2 < 1–5
Starchy roots or
tubers and products
thereof, sugar plants
1–12 4–12 5–11 5–13 6–12 7–14 7–15
Sugar, confectionery
and water-based
sweet desserts
0 < 1–1 < 1–2 < 1–2 < 1 < 1 < 1
Vegetables and
vegetable products
1–8 4–5 4–7 4–8 3–12 3–12 3–11
Water and water-
based beverages
0 0 < 1–3 < 1–3 < 1–1 < 1 < 1
‘–’ means that there was no consumption event of the food group for the age and sex group considered, while ‘0’ means that there were some
consumption events, but that the food group does not contribute to the intake of the nutrient considered, for the age and sex group considered.
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Appendix F – Minimum and maximum percentage contribution of different food groups
(FoodEx2 level 1) to thiamin intake estimates among females
Food groups
Age
< 1 year 1–< 3 years 3–< 10 years 10–< 18 years 18–< 65 years 65–< 75 years ≥ 75 years
Additives, flavours,
baking and processing
aids
0 0 0–1 0–1 0 < 1 0
Alcoholic beverages < 1 < 1 < 1 < 1 < 1–1 < 1–1 < 1
Animal and vegetable
fats and oils
< 1 < 1 < 1 < 1 < 1 < 1 < 1
Coffee, cocoa, tea and
infusions
< 1–1 < 1–1 < 1–1 < 1–2 < 1–6 1–8 1–4
Composite dishes < 1–3 < 1–9 < 1–9 < 1–13 < 1–16 < 1–14 < 1–16
Eggs and egg products < 1–1 < 1–1 < 1–2 < 1–2 < 1–2 1–2 < 1–2
Fish, seafood,
amphibians, reptiles
and invertebrates
0 < 1–3 < 1–2 < 1–3 1–4 1–7 1–7
Food products for
young population
35–63 3–14 < 1–2 < 1–1 < 1 – < 1
Fruit and fruit products 3–5 3–5 2–5 2–6 3–8 4–10 3–9
Fruit and vegetable
juices and nectars
< 1–2 1–7 2–11 2–12 1–6 1–5 2–3
Grains and grain-based
products
10–16 25–34 21–39 24–38 20–40 19–33 20–37
Human milk < 1–9 < 1–1 – – – – –
Legumes, nuts, oilseeds
and spices
< 1–4 1–7 1–6 1–5 2–7 2–7 2–6
Meat and meat
products
1–10 8–17 14–23 15–39 16–31 18–24 15–23
Milk and dairy products 3–18 15–22 10–22 6–17 5–15 7–16 8–14
Products for non-
standard diets, food
imitates and food
supplements or
fortifying agents
< 1 < 1 0–2 < 1–1 < 1–2 < 1–2 < 1–1
Seasoning, sauces and
condiments
< 1–3 < 1–2 < 1–3 < 1–3 < 1–2 < 1–2 < 1–2
Starchy roots or tubers
and products thereof,
sugar plants
3–12 4–11 5–12 5–14 4–12 5–13 6–12
Sugar, confectionery
and water-based sweet
desserts
0 < 1–1 < 1–2 < 1–2 < 1–1 < 1 < 1
Vegetables and
vegetable products
2–9 4–5 4–8 4–9 4–13 4–14 5–12
Water and water-based
beverages
0 0 < 1–3 0–2 < 1–1 < 1 < 1
‘–’ means that there was no consumption event of the food group for the age and sex group considered, while ‘0’ means that there were some
consumption events, but that the food group does not contribute to the intake of the nutrient considered, for the age and sex group considered.
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Appendix G – Comparison between EFSA intake estimates and published
estimates from the same survey
Country Survey (age range) Reference
Percentage of published
intake(a)
Finland DIPP (1–6 years) Kytt€al€a et al. (2010)(b) 100–101
NWSSP (13–15 years) Hoppu et al. (2010)(c) 100–107
FINDIET 2012 (25–74 years) Helldan et al. (2013) 100–108
France INCA2 (3–17 years) Afssa (2009) 89–98
Germany EsKiMo (6–11 years) Mensink et al. (2007)(b) 87–90
VELS (< 1–4 years) Kersting and Clausen (2003) 95–110
Ireland NANS (18–90 years) IUNA (2011) 86–105
Italy INRAN-SCAI (1 month–98 years) Sette et al. (2011) 92–107
Netherlands DNFCS 2007_2010 (7–69 years) van Rossum et al. (2011) 89–101
Sweden Riksmaten 2010_2011 Amcoff et al. (2012) 100–109
UK NDNS years 1–3 (3–94 years) Bates et al. (2012)(d) 97–108
DIPP: type 1 Diabetes Prediction and Prevention survey; DNFCS: Dutch National Food Consumption Survey; EsKiMo:
Ern€ahrungsstudie als KIGGS-Modul; FINDIET: the national dietary survey of Finland; INCA: etude Individuelle Nationale des
Consommations Alimentaires; INRAN-SCAI: Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione - Studio sui Consumi
Alimentari in Italia; NANS: National Adult Nutrition Survey; NWSSP: Nutrition and Wellbeing of Secondary School Pupils; VELS:
Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von S€auglingen und Kleinkindern f€ur die Absch€atzung eines akuten
Toxizit€atsrisikos durch R€uckst€ande von Pflanzenschutzmitteln.
(a): Range over different age groups in a specific survey.
(b): For these surveys, published intake values included supplement consumption, while the EFSA estimates are based on food
consumption only.
(c): Published values were for two consecutive days of dietary recall, while EFSA data comprised 2 9 48 h dietary recall.
(d): UK-NDNS survey published intake data for 3 years (2008–2010), while EFSA estimates are based on 4 years consumption
data (2008–2011).
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Appendix H – Summary of population reference intakes (PRIs) for thiamin
for adults expressed in mg/day
Age
PRI at PAL = 1.4
(mg/day)(a)
PRI at PAL = 1.6
(mg/day)(a)
PRI at PAL = 1.8
(mg/day)(a)
PRI at PAL = 2.0
(mg/day)(a)
Men Women Men Women Men Women Men Women
18–29 years 0.99 0.80 1.13 0.91 1.27 1.02 1.41 1.13
30–39 years 0.96 0.77 1.09 0.88 1.23 0.99 1.36 1.09
40–49 years 0.94 0.76 1.08 0.87 1.21 0.98 1.35 1.08
50–59 years 0.93 0.76 1.06 0.86 1.20 0.97 1.33 1.08
60–69 years 0.85 0.69 0.97 0.79 1.10 0.89 1.22 0.98
70–79 years 0.84 0.69 0.96 0.78 1.08 0.88 1.20 0.97
PAL: physical activity level. PAL values of 1.4, 1.6, 1.8 and 2.0 reflect low active (sedentary), moderately active, active and very
active lifestyles (EFSA NDA Panel, 2013).
(a): The ARs for thiamin in mg/day were calculated from the AR for thiamin of 0.072 mg/MJ using the ARs for energy for adults
according to the Scientific Opinion on dietary reference values for energy (EFSA NDA Panel, 2013). The PRIs were then
derived assuming a CV of 20%.
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Appendix I – Summary of population reference intakes (PRIs) for thiamin
for infants aged 7–11 months expressed in mg/day
Age PRI (mg/day)
(a)
Boys Girls
7 months 0.27 0.24
8 months 0.28 0.25
9 months 0.29 0.26
10 months 0.30 0.27
11 months 0.31 0.28
(a): The ARs for thiamin in mg/day were calculated from the AR for thiamin of 0.072 mg/MJ using the ARs for energy for infants
aged 7–11 months according to the Scientific Opinion on dietary reference values for energy (EFSA NDA Panel, 2013). The
PRIs were then derived assuming a CV of 20%.
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Appendix J – Summary of population reference intakes (PRIs) for thiamin
for children and adolescents expressed in mg/day
Age
PRI at PAL = 1.4
(mg/day)(a)
PRI at PAL = 1.6
(mg/day)(a)
PRI at PAL = 1.8
(mg/day)(a)
PRI at PAL = 2.0
(mg/day)(a)
Boys Girls Boys Girls Boys Girls Boys Girls
1 year 0.33 0.30 – – – – – –
2 years 0.43 0.40 – – – – – –
3 years 0.49 0.46 – – – – – –
4 years 0.53 0.49 0.60 0.56 0.69 0.64 – –
5 years 0.56 0.52 0.65 0.59 0.73 0.68 – –
6 years 0.59 0.55 0.68 0.64 0.77 0.72 – –
7 years 0.64 0.58 0.73 0.68 0.82 0.76 – –
8 years 0.68 0.62 0.77 0.72 0.87 0.80 – –
9 years 0.71 0.67 0.82 0.76 0.92 0.85 – –
10 years – – 0.82 0.77 0.92 0.87 1.02 0.96
11 years – – 0.86 0.81 0.97 0.91 1.08 1.01
12 years – – 0.92 0.85 1.03 0.95 1.15 1.06
13 years – – 0.99 0.89 1.11 1.00 1.23 1.11
14 years – – 1.06 0.92 1.19 1.03 1.32 1.15
15 years – – 1.14 0.94 1.28 1.06 1.42 1.18
16 years – – 1.20 0.96 1.35 1.07 1.50 1.19
17 years – – 1.24 0.96 1.39 1.08 1.55 1.20
PAL: physical activity level. PAL values of 1.4, 1.6, 1.8 and 2.0 reflect low active (sedentary), moderately active, active and very
active lifestyles. PAL values were selected from the range of PAL values observed in children and adolescents (EFSA NDA Panel,
2013).
(a): The ARs for thiamin in mg/day were calculated from the AR for thiamin of 0.072 mg/MJ using the AR for energy for children
and adolescents according to the Scientific Opinion on dietary reference values for energy (EFSA NDA Panel, 2013). The
PRIs were then derived assuming a CV of 20%.
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Appendix K – Summary of population reference intakes (PRIs) for thiamin
for pregnant and lactating women (in addition to the PRI for non-pregnant
non-lactating women) expressed in mg/day
PRI(a) (mg/day)
Pregnant women
1st trimester + 0.03
2nd trimester + 0.11
3rd trimester + 0.21
Lactating women
0–6 months post-partum + 0.21
(a): The additional ARs for thiamin in mg/day were calculated from the AR for thiamin of 0.072 mg/MJ using the AR for
additional energy for pregnancy or lactation (i.e. in addition to the AR for energy for non-pregnant non-lactating women)
according to the Scientific Opinion on dietary reference values for energy (EFSA NDA Panel, 2013). The PRIs were then
derived assuming a CV of 20%. These values have to be added to the PRI for non-pregnant non-lactating women.
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